System and Method for Biologic Particle Density Path Projection

ABSTRACT

A processing method is disclosed for projecting one or more biologic particle density paths and for defining at least one retesting time for a specific biologic particle density of a patient. The processor is programmed to process laboratory data from the patient or from a data repository. The processor identifies a pattern of a plurality of biologic particle densities and based on at least the pattern identifies a medical condition and calculates a potential worst case pattern or trajectory of the laboratory test value over time based on the pattern and/or the identified medical condition. The system may calculate or identify the retesting time based on at least the minimum change of the parameter which would have actionable clinical relevance.

This application claims the benefit of U.S. Provisional Application Ser.No. 61/770,919 filed Feb. 28, 2013, the contents of which are herebyincorporated by reference, and U.S. Provisional Application Ser. No.61/770,971 filed Feb. 28, 2013, the contents of which are herebyincorporated by reference. This application is also related to U.S.patent application Ser. No. ______, filed Feb. 28, 2014, titled “TimeLapsable Motion Image Responsive to Features of PathophysiologicPerturbations,” the entire contents of which are hereby incorporated byreference.

BACKGROUND

Human pathophysiology is highly complex and it is very difficult forphysicians and nurses to timely detect many adverse clinical conditionsin the many settings. U.S. Pat. Nos. 8,241,213, 8,152,732, 7,758,503,7,398,115 and 7,081,095, as well as U.S. patent application Ser. Nos.12/437,417, 12/437,385, 12/629,407 13/677,291, and 13/677,288 (theentire contents of each of these patents and patent applications areincorporated by reference as if completely disclosed herein) discloseprocessor methods, time series matrix analysis and objectification,processing systems, patient monitors for timely detection,identification, quantification, tracking, and generation of dynamicdisplays of sepsis and other conditions. These patents and patentapplications provide additional background for the embodiments describedherein.

Diagnostic systems and their limitations are discussed in U.S. PatentApplication Ser. No. 61/770,919 filed Feb. 28, 2013, entitled “Patientstorm Tracker and Visualization Processor,” (the entire contents of eachof these applications are incorporated by reference as if completelydisclosed herein). This application also provides background for theembodiments described herein. Some embodiments described herein relateto systems and methods for analyzing complex datasets of medicalrecords. FIG. 1 shows a conventional medical repository system 100 withassociated cognitive support 102. In this figure a central repository104 (such as Microsoft Health Vault or a hospital system's server ordata repository) may store massive amounts of clinical data, forexample, in database fields. Hospitals access the databases for clinicalmanagement of the patient 106. In many cases, patients may also observetheir own data using secure portals.

Physicians and patients often find it difficult to deal with thecomplexity of the data available from these portals and especially toidentify causation of complex or subtle perturbations. A major portionof the complexity of medical data is derived from the highlyinterrelated dynamic patterns of perturbations of the compartmentalizeddensities of human biologic particles. The dynamic complexity of therelational patterns of cascading biologic particle perturbationsprovides a major barrier to timely care.

BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments will be described hereinafter with reference to theaccompanying drawings. These embodiments are illustrated and describedby example only, and are not intended to limit the scope of thedisclosure. In the drawings, similar elements may have similar referencenumerals.

FIG. 1 depicts a conventional medical repository system with associatedcognitive support;

FIG. 2 depicts the PHM processor, some primary components, with inputfrom patient data and access from multiple institutions;

FIG. 3 depicts ialpha and ibeta events in a perturbation-recovery binaryas accessed in i-space;

FIG. 4 depicts the same perturbation-recovery binary as in FIG. 3 asseen within f-space with perturbation and recovery forces depicted;

FIG. 5 depicts a single quaternary;

FIG. 6 depicts two linked quaternaries wherein the perturbation of thefirst quaternary is the perturbation force of the second quaternary;

FIG. 7 depicts a polyquaternary distortion with many linked quaternariesincluding 2 unsolved quaternaries and a single identified apical forcecomprising an image of causation;

FIG. 8 depicts a single complete diagnostic path traversal for Sepsis inwhich solid lines between types of perturbations indicate traversal anddotted lines between types indicate no traversal. The instance depictedhas an initial occurrence of LacticAcidHigh traveling through Acidosis,Acidification, ModerateInflammationAndAcidification, andInflammationAndAcidification to Sepsis;

FIG. 9 depicts multiple complete diagnostic path traversals for Sepsisin which solid lines between types of perturbations indicate traversaland dotted lines between types indicate no traversal;

FIGS. 10A and 10B depict multiple complete diagnostic path traversalsfor Sepsis. In the example illustrated in FIGS. 10A and 10B, the pathtraversal for Sepsis includes the ModInflammatoryIndicator. The solidlines between types indicate traversal and dotted lines between typesindicate no traversal. In the case illustrated in FIGS. 10A and 10B, 3primary sub-path traversals are shown—SequentialInflammationInjury,InflammationAndPlateletDeficit, and InflammationAndAcidification.Further, 3 other primary sub-paths are shown as not beingtraversed—InflammationAndIonCalciumFall, InflammationAndAlbuminFall,InflammationAndCalciumFall;

FIG. 11 depicts perturbations, perturbation forces, recovery andrecovery forces and/or their features are rendered as hexagons placedwithin related clinical space systems;

FIG. 12 depicts an image of a severe sepsis patient in whichperturbations, perturbation forces, recoveries and recovery forcesand/or their features rendered as bars across a two dimensional area inwhich the location and length of the bar are based on the start and endtime of the associated perturbation or recovery and the verticallocation is set by the type of the perturbation or recovery grouped byclinical space;

FIG. 13 depicts an image of a sepsis patient which recovered from sepsisin which perturbations, perturbation forces, recoveries and recoveryforces and/or their features rendered as bars across a two dimensionalarea in which the location and length of the bar are based on the startand end time of the associated perturbation or recovery and the verticallocation is set by the type of the perturbation or recovery grouped byclinical space;

FIG. 14 depicts an image of a long-term severe sepsis patient in whichperturbations, perturbation forces, recoveries and recovery forcesand/or their features rendered as bars across a two dimensional area inwhich the location and length of the bar are based on the start and endtime of the associated perturbation or recovery and the verticallocation is set by the type of the perturbation or recovery grouped byclinical space;

FIG. 15 depicts an AbsNeutrophil rise perturbation and an AbsNeutrophilfall recovery rendered as hexagon clusters that include both the falland recovery along with their associated features;

FIG. 16 depicts the two linked quaternaries wherein the perturbation ofthe first quaternary is the perturbation force of the second quaternarydisplayed as an image of perturbations, recoveries, perturbation forcesand recoveries represented as clustered hexagons;

FIG. 17 depicts a perturbation/recovery pair visually decorated with theassociated forces identified in which hexagon clusters for eachperturbation, recovery and force are shown;

FIG. 18 depicts a schematic of a complex time dimensionedpathophysiologic cascade with relationally enabled links in which aunique binary object enables a connection to an otherwisenon-connectable beta;

FIG. 19 is a block diagram of an example of a computing device that canproject a path of at least one biologic particle density and a retesttime for said biologic particle density of a patient; and

FIG. 20 is a process flow diagram of an example method for projecting apath of at least one biologic particle density and a retesting time forsaid biologic particle density of a patient.

DETAILED DESCRIPTION OF EMBODIMENTS

An embodiment described herein comprises a PHM system 200 of FIG. 2 thatincludes a processor (also referred to herein as the PHM generatingprocessor 202 of FIG. 2) programmed to generate an image of causation ofadverse conditions comprising a dynamic multi-dimensional parallel timeconstruct (also referred to herein as a programmatic dynamic humanconstruct 204 of FIG. 2) of a human or patient 206 from medical datawhich may be a causation construct which is comprised of perturbationsand at least one force which caused or induced the perturbations. Thedynamic human construct 204 exists in parallel with the human andprovides a limited companion parallel instance of the biologic human. Inone embodiments, the processor 202 can be programmed to analyze theparallel human construct 204 for dynamic distortions indicative of, forexample, disease, drug reactions, age related declines in function, orother clinical failures. As constructed by the processor 202, oneembodiment of the parallel human construct 204 is comprised of a highlyorganized and compartmentalized time matrix. The time matrix may becomprised of grouped, bonded, linked, related, encapsulated, orotherwise connected events and forces which may be converted to objects.In an embodiment, four fundamental events and forces which are used tobuild the time matrix are; perturbations 302 of FIG. 3 (such as particledensity perturbations), perturbation forces 402 of FIG. 4 which inducedthe perturbations, recoveries 304 of FIG. 3 (such as particle densityperturbations), and recovery forces 404 of FIG. 4, which induced therecoveries. In one embodiment, when linked these form a “forcequaternary” (which is shown in FIG. 3). A force quaternary may be afundamental repeating structural component of distortions along at leastone portion of the PHM. According to some embodiments, this type ofdistortion of the biologic matrix is called a “polyquaternarydistortion”. A polyquaternary distortion 400 may, as shown in FIG. 4, bemodeled as a growing molecule which develops upon the occurrence of aforce sufficient to induce a perturbation 302 in the PHM and initiallyoccurs in the region of the PHM which initially receives the force. Ifthe perturbation force 402 is strong it may induce perturbation forcecascade which projects through the particle densities of the PHM andexpanding outwardly in the PHM to involve a progressively greater numberof particle densities and a progressively greater number of systems.This comprises a causation construct or a causation cascade as theforces which induce or cause the perturbations define, with theperturbations, the construct which may be for example a causation timematrix. In cascading conditions such as sepsis, the perturbation forcecascade may project along and within the PHM as a cone. The perturbationforce 402 which induced the cone is called an apical perturbation forceand is one of the causation forces of the cascade. There may be morethan one force which comprises the apical force. The apical force (whichmay be endogenous or exogenous) may have been induced or more exogenoustrigger forces.

In one embodiment, stasis, as well as perturbation 302 and recoveryobjects 304 are identified, related, aggregated and stored. Stasisobjects represent and quantify the maintenance of particle densitieswithin phenotypic ranges. Stasis object provide a positiverepresentation of equilibrium within the system. Further stasis objectscan provide quantification of the equilibrium. In one embodiment, stasisis quantified simply by referring to sections of the time series inwhich there are no perturbation or recovery events. In this approach amatrix in stasis is free of perturbation and it is the distortions whichare defined by the force quaternaries. In another embodiment, stasisobjects are defined by the normal forces which maintain the stasisobject in its normal state, which may be a variable state, such as acycling state. In this embodiment, a perturbation may be a physiologicperturbation or pathologic perturbation and recovery may be physiologicor pathologic. In this approach, recovery may be physiologic recoveryfrom a physiologic perturbation, physiologic recovery from a pathologicperturbation, or a pathologic recovery from a pathologic perturbation.With this approach the entire matrix may be defined by quaternaries tothe extent that the forces are known or reasonably assumable based onthe dynamic motion image of the matrix.

In one embodiment, stasis objects are used as building blocks which mayrepresent, at a higher level, physiologic perturbation and/orphysiologic recovery. For example, rises, falls and reciprocations inchest wall pressure may be stored in terms of stasis objects if withinphenotypic ranges. However, in the context of other objects theseobjects may represent or participate in relational objects that indicateeither pathologic or physiologic perturbation or recovery. In this way,stasis objects provide the encapsulation of state, and change in state,which can be interpreted within the wider context of the entire matrix.

In one embodiment a recovery or perturbation may also be defined asexogenous, endogenous, or mixed depending on the force which induced it.For example, an exogenous recovery can be so designated when therecovery is actually derived from outside force (such as theadministration of platelets causing a recovery of platelet density. Inthis example the recovery force (for example infusion of 6 units ofplatelets over 30 minutes), is an exogenous force and the platelet rise(recovery) responsive to the platelet infusion is an exogenous recovery.A grouping of recoveries which comprise recoveries associated with apolyquaternary distortion may be combined to generate a cascade ofrecoveries and recovery forces. If this group is endogenous, this groupor cascade may be rendered as a motion image in a visualization as forexample a motion image of a recovering storm which provides a differentvisual designation then the perturbation and perturbation force portionof the storm and a different visual designation then exogenousrecoveries and exogenous recovery forces. In this way grouping orcascades of recoveries which are exogenous or single recoveries whichare exogenous, may be identified in the matrix visualization with adifferent color or other marking so that they are not confused withendogenous recoveries by the healthcare worker. In the matrixvisualizations, each of the above different types of perturbation anddistortion and each different type of recovery may be designated bydifferent colors or by other designations.

In one embodiment the processor 202 detects and analyzes perturbationsto detect the presence of a distortion of the PHM. Upon identificationof one or more perturbations, the processor 202 seeks to solve thequaternary, diquaternary and/or polyquaternary which comprise thedistortion. The occurrence of a high and sustained force (as, forexample induced by a biologic invasion by multiplying bacteria) inducesat least one expanding polyquaternary. Since different types ofdistortion of the PHM, as for example caused by different disease types,produce different polyquaternaries, the processor 202 solves thepolyquaternary by building it, as by the identification and insertion ofa progressive number of its components into a diagnostic construct ofthe matrix distortion which optimally includes detection of the apicalforce or forces and any exogenous triggering force or forces.

Perturbations may comprise, for example, the perturbation of particledensities, perturbation of phenotypic energy states (as, for example,implied by temperature), the introduction of foreign organisms, theperturbation, reduction and/or elimination of health enhancingorganisms, the perturbation of standard motions (including variationssuch as pulsations and oscillations), the damage to structuralintegrity, the perturbation of structural and/or functional capacity,the perturbation of the mental state of the patient to name a few. Thepresence of abnormally high or low diagnostic values (such as low orhigh particle density values) may also comprise and/or be consideredindicative of the occurrence of a perturbation and may be substitutedfor a perturbation in the matrix groupings of perturbation force,perturbation, recovery force, and recovery.

According to some embodiments, the state of health or disease of anyhuman may be definable as a function of the distortions along his or herPHM. Although many types of perturbations and forces may occur, aportion of the PHM is comprised of the densities of biologic particles.Distortions comprised of dynamic perturbations and recoveries of thosedensities, and the dynamic forces acting on those densities representsome of the dangerous and diagnostic distortions of the PHM. Thedetailed approach to identification of particle density perturbations,forces, quaternaries, and polyquaternaries along the PHM provided hereinprovides examples for application to other types of perturbations,forces, quaternaries, and polyquaternaries.

According to one aspect of some embodiments, (as shown in FIG. 2) theparallel instance (which may be include distortions comprised of solvedand unsolved quaternaries) is monitored by a processor 202 for healthand disease along with the biologic instance. The parallel instance mayexist in the cloud, on a server, or another repository. As the parallelinstance ages and new data are added the instance grows incorporatingthe new data in such a way that the past instance at any time may beaccessed and/or fully reconstructed.

The parallel human construct 204 comprises a global integrated matrixcalled a “Parallel Human Time Matrix” (PHM). The matrix is constructedby a “PHM generating processor” and may be maintained in memory orpersisted to storage as needed. The PHM is “grown” and “aged” over timeover the life time of the human from which the construct is generated.

Since particle densities and patterns of particle densities in the PHMare forcefully maintained by density normalization forces a densitychange suggests either the loss of that normalization force(s), and/orthe introduction of a new force that has overwhelmed the normalizationforce. Either condition comprises the equivalent of the introduction ofan unbalanced density modifying force into the PHM which moves theparticle density in the PHM to a new higher or lower value whichgenerally will extend outside the phenotypic range producing adistortion of the PHM.

The PHM may integrate genetic code, and a sequenced human genome or asingle gene may be positioned at the beginning of the matrix (forexample as steps functions) when available. Genes or specific geneticcodes or mutations, can be converted to objects and processed by theprocessor 202 as relational objects along the matrix and compared withparticle densities, perturbations, distortions, and recoveries toidentify relationships across populations between genetic informationand the objects of the matrix. The PHM may further integrate particledensities, exogenous forces, endogenous forces, perturbations, andrecoveries, as well as structural relationships, such as anatomicrelationships. The PHM matrix may be an objectified time series matrixor another matrix construct. The PHM is monitored by a “PHM monitoringprocessor” (also referred to herein as a PHM distortion monitor 206).The PHM monitoring processor 206 may be the same general processor asthe PHM generating processor 202 and when combined they are calledcollectively a “PHM processor” or “processor” or PHM system 200.

The PHM monitor 206 comprises a processing system and method whichanalyzes the complex and voluminous medical data sets which comprise aPHM. The analysis comprises detection, identification, quantification,and tracking of cascading perturbations, the forces inducing thecascading perturbations, as well as triggering events (such as asurgical procedure) which may have induced the forces. The processoralso searches for the “apical force” 700 of FIG. 7 which comprises aforce sufficient to generate a severe distortion of the PHM (for exampleby inducing a force cascade (which may be a force polyquaternarycascade) within the PHM. The apical force 700 or forces (for exampleinvasion of the human by bacteria) generally precedes the force cascade(and is positioned in the matrix at the apex of the force cascade). Theapical force 700 is often a diagnosis such as “group A streptococcalbacteremia”. In one embodiment, the apical force 700 is a relativeconcept specific to a perspective selected by the viewer. For example, auser may be interested in the apical force 700 within a clinical space.

The analysis further comprises detection, identification,quantification, and tracking of cascading recoveries, and the forcesinducing cascading recoveries. The PHM monitor analyzes the data fromthe PHM to generate outputs which may comprise dynamic motion images offorce cascades over time. The PHM monitor may generate images whichpresent the relational complexities of the force cascades along the PHMin dynamic formats which are readily understood, such as a color radarweather-map format.

A PHM may be comprised of any suitable amount of the medical data and/orrelated medical expense data available for a given patient from theonset of data collection (before or at the time of birth) and forward.The entire matrix back to its point of origin may be constructed andanalyzed by the PHM monitor for distortions and the PHM may be viewablein relation to time as a time-lapsed motion image through the use of aPHM visualization processor which generates motion images of the PHM ina range of dynamic formats including, for example a color weather radarformat as for example described in the co-filed application, “Patientstorm Tracker and Visualization Processor”.

Each individual, or the individual's parents or guardian, may possesstheir own PHM as well as the PHMs of their children or of individualsunder their guardianship. This will give each individual, parent, orguardian, much more control over their healthcare. Individuals may storetheir own updatable PHMs, either partially or as a whole, on memorystorage device such as flash memory card which may, for example, beintegrated with their driver's license or another storage device such asa hard drive, or a secure access cloud site. The PHM generator may beprogrammed to automatically update a PHM on a storage device when thedevice is connected with the PHM generator.

The individual PHM of each patient in a healthcare system may be storedin the cloud where each may be updated when new data is available. Thehealthcare system may deploy one or more PHM monitors to monitor each ofthe PHMs in the cloud whether the client is in the hospital or not. Anindividual may choose to have the raw data (which is preferably storedas part of the PHM), the PHM itself, and/or the output of the PHMmonitor reviewed by an expert physician on a periodic basis and toupdate the PHM or correct the configuration with her or his expertinput.

The time-lapsed representations of a personal PHM may be animated in arange of alternative formats and viewed on a device such as a smartphone, iPad, Galaxy tablet, or Surface tablet to name a few. At leastone animation is preferably readily understandable by individualswithout medical training. Individuals may view their own PHMs or thoseof their children from the storage site using a PHM visualizer. PHMs maybe updated while a patient is in the hospital or emergency room as bysecure smart phone, password protected Wi-Fi or other securetransmission, so that the individual, parents, or other approved familymembers are updated in a manner wherein they may readily seekalternative PHM review, an alternative PHM monitor, or expert who may beremote for the hospital.

According to one aspect of some embodiments, although the PHM mayfunction as a comprehensive medical data repository for each individual,it is actually a dynamic, growing, and highly portable, parallelrepresentation of the dynamic state of health and/or disease of therepresented individual within the limitations of the available data Likethe individual, the PHM may be continuously or periodically updated andmonitored to determine the PHM's state of “health”.

In one embodiment, the PHM processor 200 monitors the parallel patientconstruct (the PHM). Both the healthcare workers and the PHM may monitorthe actual biologic patient, asking questions, applying tests, andphysical evaluations, updating the PHM and the healthcare worker. Inaddition, both the PHM processor 200 and the healthcare workers fromInstitution A 208 and Institution B 210, among others, monitor eachother to optimize quantity, timeliness, and efficiency of care. The PHM,upon identifying a distortion comprised of abnormal physical findings,test result, and/or historical finding, the PHM may identify linkagesand images which comprise primers of the image of the distortion andupon the detection of one or more primers, generate one or morequestions for the patient, or ask the healthcare worker to examine aphysical portion of the patient, the answers and/or results to which mayhelp improve the image in the PHM. At the discretion of the healthcareworker or when the worker is not available, the PHM may ask the patientdirectly in text or voice or the PHM may offer the questions to thehealthcare worker so that he or she may ask them. In this way the PHMprocessor 200 uses dynamic image primers of specific distortions (or thelack thereof) to focus or expand the medical history and physical aswell as clinical testing.

FIGS. 4 and 5 shows examples of basic “building blocks” comprised ofperturbations and matched recovery, with matching forces, which definethe fundamental building components (which may be objects) of the PHM.In one embodiment as shown in FIG. 5, the PHM processor 200 detects andlink a set of at least 4 components of a distortion quaternarycomprising, a perturbation 502, the matching perturbation force 504(which is capable of inducing, and may have induced that specificperturbation), a recovery 506 (from the perturbation or in response tothe perturbation), and the matching recovery force 508 (which is capableof inducing and may have induced the recovery). In one embodiment of thePHM, all of these components are converted objects that are linked inthe timed sequence of their occurrence with the distortion itself beingcomprised of a solved or unsolved quaternary or polyquaternary. In oneembodiment, each distortion is comprised of only one quaternary orpolyquaternary and when two quaternary or polyquaternary are presentthey are either linked (and this link has not been detected) or thereare two distortions. The processor 200 seeks a common link for (or alink between) the apical forces (or another force or perturbation) ofeach polyquaternary or seeks common exogenous trigger force for each.

The PHM generator may use combinations of each of these objects andparticular the combination of all four of these objects to build or“grow” the distortion by linking additional groups of these objects asshown in FIG. 6. As shown in FIG. 6, the perturbation of one groupingmay be the perturbation force of a second grouping as these are detectedand linked the processor 200 generates a force cascade of perturbationsand forces which mirrors those operative in the patient. As will bediscussed there will be gaps in the distortion but one goal is to buildthe image sufficiently to detect the primary cause of the distortionsuch as a “force-cascade precipitating force”, which is generally anapical force 700 (designated as such as it generally exists (or existed)near the origin (the apex) of the expanding force cascade whichcomprises the distortion as shown in FIG. 7.

FIGS. 6 and 7 show linked polyquaternaries. The example illustrated inFIG. 6 includes perturbation B1 602, perturbation B2 604, perturbationforce A1 606, perturbation force A2 608, recovery T1 610, recovery T2612, recovery force Sigma1 614, and recovery force Sigma2 616. However,typically, during early distortions in the PHM due to an unknown butdangerous process, only perturbations are initially evident along thedistortion and the polyquaternary 600, which will in the future, whensolved, identify, quantify, and define the distortion is incomplete. Inan example, it is typical of in early sepsis before the diagnosis ismade by the clinician or processor 200 for the distortion of the PHM tocomprise only perturbations although many of these will be compensatoryperturbations which mitigate movement of critical densities away fromnormal values. In other words, in early sepsis the FIGS. 6 and 7 wouldbe comprised almost entirely of perturbations.

One of the purposes of the PHM processor 200 is to solve thepolyquaternary as soon as reasonably possible since upon the solution ofthe polyquaternary the processor 200 may be able to render a diagnosis,quantify the condition, project a “near worst case” path of at leastpart of the distortion, and provide direction for treatment or treatmentmodification. In many cases the processor 200 may solve thepolyquaternary with only perturbations, inserting the forces, andespecially the apical force when the processor 200 has solved thepolyquaternary and determined its identity. The completed distortion isgenerated when the polyquaternary has been solved although there may bemissing forces and particularly recovery forces if the polyquaternaryhas not yet extinguished along the PHM. Many of the cascading forces maybe completed by the processor 200 when the apical perturbation force issolved and the diagnosis made. The time pattern of the recovery forcemay be used by the processor 200 to characterize the recovery patternsof the polyquaternary distortion.

Along the polyquaternary, relational timing of the apical perturbationforce, treatment potential triggers, treatment, identification and thedurations, including of the expansion and contraction portions of thepolyquaternary are all defined to determine quality of care. Thepolyquaternary is displayed, for example in relation to time, toillustrate the timing relationships.

The PHM monitor is programmed to detect dynamic distortions in the PHM,and generate processing decisions. Collectively a unified PHM processor200 may perform all of these tasks. The PHM processor 200 may link twoof the four objects such as a perturbation objects and the matchingperturbation force object, or the recovery and the matching recoveryforce, or the perturbation and the matching recovery from or in responseto the perturbation, or the perturbation force and the recovery forcewhich induced the recovery from the perturbation induced by theperturbation force, or the perturbation force and the recovery from theperturbation, or the perturbation and the recovery force which inducedthe recovery from the perturbation, as well as three or all fourcombined components as decision points (such as the ordering ofadditional testing), or decision components, and also to link to otherevents or combined components.

In one embodiment, (as shown in FIG. 5) the PHM processor 200 links thequaternary and then uses the quaternary as a “primer” to build apolyquaternary. However, as noted, the processor 200 may only have oneor more of the perturbation objects available to use as the primer. ThePHM processor 200 may be programmed to, upon detection of the primer,complete the image by linking available data or to order additionaltesting to complete the image.

The PHM processor 200 may combine a perturbation object with aperturbation force object to generate a “perturbation force binary”object. The PHM processor 200 also may combine a recovery object with amatching recovery force object to generate a “recovery force binary”object. These two binaries may be combined by the PHM processor 200 togenerate the “perturbation-recovery force quaternary” of FIG. 4. Theseforce binary objects and force quaternaries may be linked to otherbinaries and quaternaries to build highly complex, time dimensionedimages. The PHM processor 200 may then construct very large and highlycomplex force cascades, such as sepsis force cascades of; triggeringexogenous perturbation forces, (such as a surgical procedure),endogenous perturbation forces, perturbations, and exogenous recoveryforces (such as an antibiotic or surgical intervention), and endogenousrecovery forces, using basic binaries, the quaternaries, and/orindividual events or forces. The PHM processor 200 may also create anduse trinaries, or other basic building objects which combine multipleobjects. The PHM processor 200 may then generate motion images of theforce cascades of objects comprised of perturbations, recoveries,forces, binaries, quaternaries, diquaternaries and polyquaternaries,which may comprise a distortion or set of distortions of the PHM.

The processor 200 may be programmed to provide processing systems andmethods, which analyze dynamic pathophysiologic force cascades ofperturbation of the densities of biologic particles and recoveries ofthe densities of biologic particles (and particularly force cascades ofperturbation and recoveries of densities of biologic particles inducedby sepsis), along with associated individual, relational and forcecascades of the forces inducing the perturbation and the forces inducingthe recoveries of the densities, and for presenting the force cascadesof the perturbation and recoveries as well as the perturbation forcesand recovery forces in a motion picture responsive to or indicative offorce cascades of perturbation, which may be linked to force cascades ofperturbation inducing forces, which may be linked to force cascades ofrecoveries, and which may be linked to force cascades of recoveryinducing forces.

The processor 200 may be programmed to identify those perturbations orrecoveries for which the processor 200 does not identify theperturbation inducing force and/or the recovery inducing force. In oneembodiment the processor 200 is programmed to identify those forcecascades of perturbation and/or recoveries for which the processor 200does not identify the force cascades of perturbation inducing forcesand/or force cascades of recovery inducing forces.

The processor 200 may be programmed to identify those perturbationinducing forces and/or the recovery inducing forces for which theprocessor 200 does not identify the perturbation and/or the recoverywhich the forces are expected to induce. The processor 200 may beprogrammed to identify those force cascades of perturbation inducingforces and/or force cascades of recovery inducing forces for which theprocessor 200 does not identify the force cascades of perturbationand/or the force cascades recovery which the forces are expected toinduce.

The processor 200 may be programmed to analyze (which comprises forexample, detection, identification, quantification, and/or tracking) theindividual perturbations and/or force cascades of the individualperturbations and to analyze the individual perturbation inducing forceswhich induced the individual perturbations and to link and/or link in aoutput or display, the individual perturbations which are induced by theforce and the force cascades which are induced by the force or inducedby a force cascade of forces.

The processor 200 may be programmed to analyze and link individualperturbation inducing forces, to individual perturbations, and toindividual recovery inducing forces and to individual recoveries. Theprocessor 200 may be programmed to link the individual recoveries to theindividual perturbations which are reversed or corrected by theindividual recoveries, and to analyze at least one force cascade ofperturbations and at least one force cascades of perturbation forces andat least one force cascade of recoveries and at least one force cascadeof recovery forces.

The processor 200 may be programmed to generate a linkage chain or atemporal cluster of linkages and to link a perturbation and/or a forcecascade of perturbations to a perturbation inducing force or a forcecascade of perturbation inducing forces, and further to link a recoveryand/or a force cascade of recoveries, which reverses or corrects theperturbation and/or force cascades of perturbations, to the force orcascades of forces inducing the recovery and/or force cascades ofrecoveries, link the perturbation and/or force cascades of perturbationsto the recovery and or force cascades of recoveries, link theperturbation inducing force and or force cascades of perturbationinducing forces, to the recovery inducing force and/or force cascades ofrecovery inducing forces. The processor 200 may be further programmed tolink other events, such as for example exogenous actions and/or geneticinformation to at least a portion of the linked chain or spatial and/ortemporal cluster of linkages.

The processor 200 may be programmed to analyze a sepsis force cascade,its onset (which may comprise the onset of early inflammatoryaugmentation), its evolution, its expansion, its peak, and its recoveryin relation to endogenous forces, such as perturbations in biologicparticle densities or organ dysfunction, as well as exogenous forces(such as exogenous actions) such as surgery, central line placement,initiation of intravenous nutrition, antibiotics, to name a few. Theprocessor 200 may be programmed to link the force cascades to otherfactors or objects such as the healthcare worker, hospital location,cost of care, to name a few.

SUMMARY

In one embodiment the PHM is comprised of the following components:

A first objectified time series sub matrix (called a “phenotypic submatrix”) comprised of the objectified phenotypic densities of biologicparticles during health;

a second objectified time series sub matrix (called a “perturbation submatrix”) comprised of objectified perturbations of densities of biologicparticles;

a third objectified time series sub matrix (called a “perturbation forcesub matrix”) comprised of the objectified forces inducing theperturbations of the second sub matrix;

a fourth objectified time series sub matrix (called a “recovery submatrix”) comprised of the objectified recoveries of the biologicparticle densities from the perturbations of the second sub matrix;

a fifth objectified time series sub matrix, (called a “recovery forcesub matrix”) comprised of the objectified forces inducing the recoveriesof the fourth sub matrix;

and a sixth objectified time series sub matrix (called a “chronicallydistorted sub matrix”) which contains objectified densities of biologicparticles which, after being perturbed, have remained persistentlydifferent from their phenotypic densities.

Each of these matrices may have a companion objectified expense matrixfor incorporation into the PHM. Additional objectified time seriesmatrices, for example comprised of the forces (which may be geneticcode) inducing the densities of biologic particles of the phenotypicmatrix and/or stabilizing the particle densities of the phenotypicmatrix may also be provided. Any or all of these sub matrices may beanalyzed or viewed separately or as components of a unifying PHM.

Historical information and subjective symptoms may be included as stepfunctions in the PHM. In an alternative embodiment, historicalinformation is entered as externally supplied events. In an example, aninput of a historical symptom of diarrhea “lasting for a week about onemonth ago” could result in this symptom being added to the PHM at thetime subjectively specified. The patient could enter this informationwith the PHM being built as the patient answers the questions aboutmedical history and symptoms. Subjective times may be given a range,which may be a fuzzy range, in the PHM. In an example, the objectdiarrhea as subjectively specified above is marked with a range of timerather than a specific time. During an analysis of the PHM subjectivetimes are defined by their ranges. The PHM processor 200 may beprogrammed with additional supplemental questions to provide greaterclarification and specificity to a positive answer (like the presence ofdiarrhea). Annotations may also be embedded in historical objects, forexample a narrative of the history of the chief complaint may beembedded as a digital, read only, or other file in the PHM with linkageto the time to which the history references and the time it wasacquired. In an example if a patient indicates that he or she developeddiarrhea on a particular date, the onset of diarrhea may be insertedinto the matrix at the time specified but with a subjective flagindicating that the data is subjective and may not be highly reliable.The subjective history of the chief compliant and the medical historymay be incorporated by the processor 200 into the matrix building amatrix which includes a timed medical history at the times wherein thehistorical events actually occurred (as subjectively or objectivelydetermined). In this manner the PHM processor 200 projects the PHM backin time, filling in gaps along the historical matrix with subjectivesymptoms, diagnosis, and physical findings. In one embodiment subjectivephysical findings are incorporated into the matrix at the time they arediscovered and/or they placed at a time along the matrix when they werediscovered if the physical findings were present in the past. Subjectivephysical findings may be recovered as step functions in the matrix. Ifthey are quantifiable a numerical scale suitable for subjectivegranularity may be included (for example 0-5 for normal, marginal, mild,moderate, severe, profound).

While portions of this historical narrative (called “hot” portions) maybecome timed structural objects of the PHM (from which force,perturbation, and recovery analysis as described herein may beperformed), the narrative itself may be stored in the PHM with theportions which are “hot” also representing hot links from the narrativeto their timed positions in PHM. A similar approach may be taken fortests such as an echocardiogram, chest radiograph, or CAT scan. The“hot” portions from these studies are added to the PHM while thenarrative reports are also embedded in the PHM at the time ofacquisition. Examples of hot portions in the report may include thepresence of a diagnosis and any numerical, measuring, scoring, orgrading, (such as the presence of heart failure with lung congestionseverity grade 2 of 5, cardiothoracic ratio of 0.6, a left ventricularejection fraction of 0.24). The digital studies are also embedded in thePHM (for example, as read only or interpretable files) accessiblethrough the PHM or the hot links in the narrative.

The ability of a physician or other worker to perform program assistedor unassisted interpretation of such studies is greatly enhanced by theavailability of the PHM in relation to the study at the time ofinterpretation. In one example, the interpreter, or the processor 200,in response to the interpretation, may add links to events, binariesand/or force cascades in the PHM thereby assisting the processor 200 orhealthcare worker in interpretation of the clinical relevance of thefindings of the study to the global PHM. As with the PHM assistedhistory and physical examination, the PHM, upon identifying primerscomprising, for example, findings in the study linked to relevant imagesin the PHM, may generate one or more questions for the interpreter, theanswers and/or results to which may help improve the image in the PHM.At the discretion of the interpreter, the PHM may ask the interpreterdirectly in text or voice. In this way the PHM processor 200 usesdynamic image primers (or the lack thereof) to focus or expand theinterpretation of clinical tests such as chest radiographs, CT scans,electrocardiograms, echocardiograms, or peripheral blood smears to namea few.

One example of a hot portion of a study is a result or finding whichwarrants detection of the force which caused the result or finding orwhich warrants detection of recovery or stability of the test or result.For example, a finding of a cardiothoracic ratio of 0.6 results in adetection of the force (for example, heart failure, pericardialeffusion, cardiomyopathy, or valvular heart disease) which caused thehigh ratio. A high cardiothoracic ratio is therefore a hot portion ofthe chest radiograph interpretation and comprises an theta for which theprocessor 200 will seek an falpha and designate the binary as unsolvedif an falpha is not identified. The processor 200 may also be programmedto expect hot portions in the interpretation (in this example, anindication of the measured cardiothoracic ratio) and to consider theinterpretation incomplete if a hot portion is missing. The processor 200may be programmed to send a notice to the interpreter to complete thehot portion or to warn before saving of the interpretation that a hotportion is incomplete. The processor 200 based potential linkages mayproceed in real time and may displayed with the relevant segment of thePHM for the interpreter as in a window, as he or she dictates or entersthe interpretation. In an example, the identification of the highcardiothoracic ratio may link to a high brain naturetic peptide (BNP)result, a low left ventricular ejection fraction, a pericardial effusionidentified on a chest CT scan, and/or a high blood pressure result.These real time linkages do not indicate cause and effect but rather areparts of the dynamic image of the PHM.

An PHM may be generated which is comprises of all the data, narratives,reports, objects, and sets for which medical related data is available,from the beginning of data acquisition to the point of analysis. In oneembodiment, the PHM is constructed as a single integration, comprised ofall the objects and time series of objects available. The PHM comprisesa medical records repository of linked objects comprising, perturbationforces, perturbations, recovery forces, and recoveries. Theconfiguration and distortions of the PHM and its objects are monitoredand analyzed to detect disease, drug reactions, recovery, the need foradditional testing or treatment, etc.

The PHM may be divided into compartments or regions. A region of the PHMmay be comprised of a set of time series of objects which relate to aspecific organ or system. In one embodiment, the PHM is a largecompartmentalized matrix dynamically changing in configuration inresponse to continuous or intermittent flow of medical data. Accordingto some embodiments, the dynamic states of human disease are analyzed bythe PHM monitor and outputted to health care workers as direct functionof the detection and analysis of dynamic distortions of the PHM.

The PHM is constructed so that the biologic forces and biologic particledensities are highly interrelated. Furthermore, the particle densitiesand forces are substantially all potentially linked, or otherwiseconnected to each other in the PHM. For this reason, a new perturbationor a new perturbation inducing force in one region of the PHM willgenerally induce a dynamic distortion of the PHM which may extend toother regions of the PHM. This distortion will push or pull on otherconnected portions of the PHM causing secondary, tertiary, and at timescascading dynamic distortions along the PHM. These distortions (ascomprised of polyquaternaries) are linked, and the processor 200 isprogrammed to follow and build the distortions and the motion image ofand/or responsive to the linked distortions, and to output the motionimage.

Pathologic PHM distortions are not present or are minimal in health.However, physiologic distortions of the PHM are normal in health, asduring exercise, or stress. These physiologic, time-dimensioneddistortions extend along anticipated regions of the PHM fromperturbation force, to perturbation, to recovery force, to recovery,each linked in the PHM to each other to generate a complex physiologicPHM distortion. This distortion may be a “physiologic polyquaternary”. Atime segment portion of the PHM before a physiologic polyquaternary andafter a physiologic polyquaternary is essentially identical whereas theyare often different after a pathologic polyquaternary due to residualinjury of the matrix.

As discussed in detail below, one embodiment comprises a PHM processor200 which renders motion images derived from a limited PHM and/or theentire PHM. These images of the PHM may comprise for example, motionimages of, indicative of, and/or responsive to a human phenotype or toPHM distortions. In one embodiment the distortions are outputted ascomplex, linked, cascading PHM distortions indicative of human diseaseand/or recovery from disease. The distortions may include linked imagesof objectified expense perturbations associated with the PHMdistortions. Distortions of the PHM in one region may be compared withdistortions of the PHM in the expense region.

The biologic particles which potentially comprise the PHM of someembodiments are vast in number and diversity. Yet, virtually all ofthese particles present in the PHM in high density relative to theenvironment. These particles comprise for example; ions, (such as; H+,K+, or Na+), endogenous molecules; (such as H2CO3, glucose, albumin orbrain naturetic peptide); therapeutic molecules (such as levofloxacin,spironolactone, furosemide or cyclophosphamide); endogenous cells orother macro structures, (such as red blood cells, nucleated red bloodcells, neutrophils, or platelets); and invasive particles (such as groupA Streptococcus, lipopolysaccharides, Strongyloides stercoralis,peptidoglycan fragments, or bacterial DNA fragments).

The densities of various types of biologic particles in any givencompartment of the PHM are generally different than the environmentaldensity of that particle and often different than the density of thesame particle in other compartments of the PHM. The relative particledensities in each compartment of the PHM are derived by clinical testingof human compartments (which may be invasive or non-invasive testing).Each patient has density defining forces which determine the densitiesof the biology particles under their influence. These density definingforces generally maintain each specific particle density at virtually asingle density value, pattern of values, or within a very narrow densityrange. In health and the non-stressed state, the density range for eachparticle in each PHM compartment in relation to environmental andnutritional factors is specific to the genetic code of the individualhuman under test. Each patient generally has his or her own phenotypicdensity range for each biologic particle type in each PHM compartment.These phenotypic density ranges are much different than populationdefined “normal” densities. In one embodiment, the processor 200determines the phenotype for the PHM compartmental densities of biologicparticles by analyzing the phenotypic components of the PHM (derived ina state when the health of the patient and densities are at theirresting baseline and wherein the densities are “unperturbed”, forexample, not acute or sub-acutely stressed) or of the phenotypic submatrix.

One embodiment defines the phenotypic or population variability of atest around a measured value (which may, in some cases, be less than theinter-measurement variability due to the testing instrument itself. Thepatient's baseline and the phenotypic or population variability are usedto define the phenotypically normal range for the patient rather thanthe use of the population normal range.

Each of the biologic particle density objects in the phenotypic submatrix has, for example, the characteristics of absolute unperturbeddensity value, relative unperturbed density, and unperturbed densityrange, variability, and/or pattern. A phenotypic sub matrix may comprisea dynamic image of the densities of any or all compartments, physiologicsystems, or physiologic grouping of cells. In one embodiment a segmentof the PHM from a healthy young human at rest is used to define thefuture phenotypic values and ranges for future reference. The phenotypicranges change as the patient ages and may be reassessed periodically.

As discussed, when defined statistically, the human population generallyhas a much wider range of so called “normal” particle densities than isdefined by the unperturbed variability associated with any individualparticle density phenotype. The common use of, for example, defining“normal” for an individual patient as a range of 2 standard deviationfor the high limit of a population and a 2 standard deviation range forthe low limit of normal of a population is incomplete. While the PHM mayincorporate objects which relate to these traditional thresholds forreference, distortions of the PHM induced by these types of thresholdsare considered along with the actual distortions in relation to thephenotypic ranges in the analysis process.

According to some embodiments, the phenotypic range for each densityvalue is defined as the phenotypic range of the density value in aphenotypic sub matrix or when the PHM is undistorted by any activenon-genetic force. The phenotypic range is ideally determined for eachindividual by making multiple measures over time but this is often notpractical. For this reason, in one embodiment, the phenotypic range isdetermined by examining the individual ranges within individualphenotypic sub matrices of a large population. This range is thenapplied around the density value of the phenotypic matrix which isgenerated for the individual during a clinical state of health. Therange may be defined by statistical methods but in this case it may forexample, be the standard deviation of the individual ranges ofunperturbed density variations in the population, rather than thestandard deviation of densities in the population itself. Since theposition of the density value in the range may not be known, anadditional cushion may be added (such as one or two average deviationsor standard deviations) to the high and low phenotypic range.Measurement of additional phenotypic densities, when available may beused to better identify the range and allow elimination of the cushion.

In one embodiment the PHM processor 200 is programmed to generate alarge set of phenotypic populations sub matrices from healthyindividuals during a non-stressed state of health and, analyze the submatrices to define the phenotypic ranges of objects in the sub matricesand to define the phenotypic ranges of the unperturbed variabilityaround the individual density values.

According to some embodiments, at least one phenotypic PHM distortionmay be defined by analysis of a PHM distorted by a non-genetic force.This may be identified if a known perturbation force, such as a new orincreased particle density of a drug, is introduced into the PHM and theperturbation induced by the force was within the expected range. Thespecific or general distortion of the PHM in response to theperturbation force induced by the drug may be defined as a specifiedforce induced phenotype of that PHM.

Both the phenotypic sub matrix and the PHM distort with age but areoften highly stable within periods of an individual's life. In oneembodiment the rate of distortion with age of the phenotypic sub matrixand/or the PHM may be tracked and compared with other individuals orpopulations.

In one embodiment, the processor 200 defines human compartmentalparticle; densities, density perturbations, density recoveries, densityrate of change, and density momentum mathematically by time seriesderived amplitude and slope formulae. The movement of a mass ofparticles into or out of a human compartment, or the consumption ofparticles within the compartment is inhibited by an aggregate resistance(modeled for the purpose of illustration as a human particle fluxresistor) which is initially genetically defined and comprises aphenotypic density flux resistor. Particle flux resistance is particleand compartment specific and is initially phenotypically defined but maythen be affected by disease, injury, environmental, nutritional, and/oraging factors. Particle flux resistance is a function of human systems,and may include a combination of factors such as membrane fluxresistance, molecular buffers, molecular or ion pumps offsetting theflux, and organ compensation, to name a few.

Particle flux resistance may not be measured but is rather generallyinferred by the time series pattern of the particle density in relationto the time series pattern of forces which potentially affect theparticle density. These forces may or may not be detectable ormeasurable but are inferred as a function of particle density timeseries patterns. Low particle flux resistance may also be identifiedwhen particle densities which are stable phenotypically begin to varywidely (for example, oscillate) when no major exogenous forces areactive. One example of this is the development of oscillation of oxygenmolecules in the arterial blood compartment which may occur inassociation with severe decline on left ventricular function. In thisexample resistance to particle density flux (of arterial oxygenparticles) has declined due to loss of sufficient flow rate of arterialblood. A normal arterial blood flow rate normally allows a centralcontroller of the brain to respond to changes in oxygen density rapidlyand therefore promptly resist the particle flux. Particle fluxresistance may be also affected by exogenous factors (such asmedications). In an example, an ACE inhibitor which improves leftventricular function may increase the resistance to the particle flux ofarterial oxygen in the example descried above but decrease theresistance to positive K+ particle flux in venous blood.

A perturbation of particle density is generally caused by a force changewhich is associated with energy and work. According to some embodiments,a relative indication of the energy or work associated with aperturbation may be calculated. The density change is a direct functionof the cumulative mass of the particles which are moved by the force (orthe mass of other molecules such as water, which are moved into or outof the compartment to dilute or concentrate the particles). For thepurpose of relative measurement, the density change may be substitutedfor the particle mass moved so that the amplitude of the particledensity change may be substituted for the magnitude of the particle masswhich moved across the resistor during the perturbation. The aggregatemomentum of the density change (for a given perturbation or group ofperturbations) may then be calculated as the product of the change indensity (surrogate for the mass which moved) and the rate of densitychange (the velocity of movement of the mass).

Since the particle flux resistor actually comprises a system resistanceto particle mass movement and is not generally calculated or known, themomentum associated with any perturbation is relative. A decline inresistance will increase the perturbation for the same force (andincrease the apparent momentum as calculated above) but since both adecline in resistance and increase in a force are simply components ofthe same density change vector, the model of aggregate particle momentumfor the purpose of medical diagnosis remains valid. In other words,since disease, such as infection, may lower the resistance to particlemass movement and/or may apply a force to induce particle mass movement,these relative effects are not readily separated and are thereforecombined to generate the value of the “functional momentum” of aperturbation or recovery. Human life, and the integrity of the humansystem, is functions of the particle density and, as noted, this issubstituted for the mass in the above equation for this model.Furthermore for the purposes of processor 200 based assessment variousmeasurements such as milliequivalents (meq) may be substituted for themass in the calculation of density.

As it relates to the state of life and health of a human system, theabsolute values of a particle density or the absolute values of aparticle density change of different particle types are notmathematically comparable either from a severity or probabilisticperspective. For example, a density rise of 7 meq/100 cc of bicarbonatein venous compartment (which would, in most cases not generally causedistress) does not comprise the same severity as a density rise indensity of 7 meq/100 cc of potassium (which would generally be fatal).In many cases a severe a deviation above a threshold of one particledensity may comprise a much less severe event than a mild deviation ofanother particle. To adjust for this disparity provide and image whichis indicative of global perturbation severity and recovery, oneembodiment comprises a processor 200 programmed to convert the absoluteparticle value types of; densities, density changes, densityperturbations, and density recoveries, density rates of change, and/ordensity momentums, to “human numbers” called R which are more indicativeof the human relevance of those values and which are comparable across awide range of particles and value types. The conversion generates a“Human Life Relevance scale” (an “R scale”) for the densities, densityperturbations, density recoveries, and density velocity (rate ofchange), and density momentum (the product of the rate of change and theduration of the perturbation or recovery) thereby providing a comparablemathematic quantifications of these values in relation to the stabilityof human life.

In one embodiment, the processor 200 applies a process of conversion ofparticle density values to the human life relevance scale which may, forexample, comprise the application of direct conversion formulae butgenerally a conversion table for each particle and value type ispreferred because these relationships of these values to human life arenot linear or readily defined by formulae. Using the conversion method,the processor 200 converts the absolute value into density relevancevalues DR which are unit less numbers. These conversions are processedin relation to a central point which comprises the normal range for theindividual human which can, for example be designated by as 0 DR. Asimilar approach may be applied to convert perturbations, forces,recoveries, binaries, and images to respective R scales.

In one embodiment the density value range above the phenotypic range areconverted by the processor 200 to a range of values from a first DR to asecond DR (such as 1 DR and 15 DR). The particle density range below thephenotypic range may also be normalized from a first DR to a second DR(such as −1 DR and −15 DR). The value 0 may be specified for alldensities in the phenotypic range, or may be set to the median oraverage value of the phenotypic density for the individual or the normalrange for the individual human may, for example be designated as notedabove by a range of 0-0.9 DR. If the phenotypic range is unknown 0 maybe set to the median or average value of the population range until aphenotypic range may be established.

These conversions may be designated by the processor 200 with theparticle, the compartment, and the DR (such as potassium, venous, −12 DRwhich indicates a dangerously low venous potassium). The term low may beadded (−12 DR low) to assure the position of the potassium is instantlyrecognized by the researchers and programmers (as these designation arenot for use by the healthcare workers, who, being trained with absolutedensity values, may become confused by the conversion).

As with the conversion of density changes discussed above, one purposeof the conversion is to allow comparison of severity of density valuesacross different particle types. In one embodiment the conversion curvesderived from the absolute values are configured with a hysteresis sothat the values become more rapidly closer to 15 or −15 as the extremesof the potential range of the values are approached.

An example of a heuristically derived DR for venous H2CO3 when sepsis,diabetic ketoacidosis, methyl alcohol intake, or lactic acidosis patternor image primers (which may for example include an elevated anion gap)are present comprises:

-   -   Venous H2CO3 (in meq) (on left)—converted to DR (on right)    -   <16-15, 16-15, 17-15, 18-14, 19-13, 20-12, 21-10, 22-8, 23-4,        24-2, 25-1, 26-0, 27-0, 28-0, 29-0, 30-1, 31-2, 32-3, 33-4,        34-5, 36-6, 37-7, 38-8, 39-9, 40-10, 41-11, 42-12, 43-13, 44-14,        44-15, >44-15        In this conversion the elevated DR even in the low “normal        range” and the rapid elevation of DR for each incremental H2CO3        value below 26 reflects the acuity of danger these densities may        reflect. Since acidosis reflects often reflects a more dangerous        dynamic in sepsis then in diabetic ketoacidosis higher DR may be        selected for sepsis then for diabetic ketoacidosis. When two        venous H2CO3 data values are available an actual perturbation        will be detectable and this can be converted to PR using a        perturbation conversion set. A second conversion below of H2CO3        (on left) to DR (on right) provides gradation of severity only        in the direction of progression of sepsis. In this example high        normal and high Venous H2CO3 are given no severity weight.    -   <16-15, 16-15, 17-15, 18-14, 19-13, 20-12, 21-10, 22-8, 23-3,        24-1, >25-0,

If preferred the phenotypic range or the population normal value may beconverted to DR from −0.9 and 0.9 so that density changes within thisrange may be tracked. The conversion curve for DR between −0.9 and 0.9may also be configured with a hysteresis so that the DR become morerapidly closer to 0.9 as the extreme of the normal range is approached.

Like the conversion for densities, the conversion to R values alsoallows, for example, “human life relevant perturbation” (RP−) to becomparable across different types of perturbations. For example, for apotassium rise, the conversion to RP may be formulaic or a directconversion of for example 0.2 miliequivalent of potassium rise for eachRP between 1 and 15. Alternatively the RP− may be a combination of thedensity change and the absolute peak or nadir value reached. Forexample, a rise of 2 meq. of potassium to a peak of 5 meq. may generatea lower RP− then a potassium rise of 2 meq. to a peak of 7 meq. Eachdensity rise may be combined with the peak produced by that change togenerate a RP between 1 and 15 and this may be performed heuristicallyand then modified over time to enhance performance as it becomes evidentthat different RP are preferred. The use of the peak value incombination with the density change is consistent with the flux resistormodel as applied in one embodiment as described above as the resistanceto a density change is reasonably assumed to be higher as the peak ofthe change vector encroaches into extreme and/or dangerous densitylevels. The human system may have secondary layer of protectiveresistance near extremes so that resistance may suddenly increase whendensity levels rise or fall to values near the extremes. According toone aspect of some embodiments, the conversion curve for particledensities and peak or nadir values which fall within a specific rangecompatible with life, may demonstrate a prominent hysteresis nearextremes.

In addition to the lack of direct comparability of absolute densitychanges between particles, one perturbation or abnormal value of aparticle density caused by one force, may be much less severe, as itrelates to immediate risk, than an identical density perturbation of thesame particle density caused by another force. This may not be accountedfor by a conversion severity scale unless the scale is adjusted fordifferent perturbation forces or clinical conditions which inducing thedensity. In an example a H2CO3 of 22 which has fallen due to volumeexpansion is considered representative of mild severity whereas the sameH2CO3 due to sepsis is considered representative of high severity. Auniversal conversion scale to a human severity value will not solve thisproblem of diversity of severity. The PHM may be programmed to have toapply different severity scales or otherwise adjust the severity of theparticle density based on the image (for example a sepsis image) ofwhich it is a component or based on a detected force which may beinducing induced the particle density. This is referred to herein asconditional severity adjustment. Alternatively or in combination theseverity of the H2CO3 is not adjusted in this manner by the processor200 upon detection of the image or force, but rather the force binaryitself is designated with the high severity, that is the force binarycomprises the conditional severity adjustment as a function of itscomponents. This may be achieved by applying different severity scalesto different force binaries even though the severity of the theta of thebinary is not adjusted. This may prevent confusion by many healthcareworkers who may find it difficult to mentally accept different severityindications for the same density value of the same particle.

One embodiment estimates a density velocity associated with theaggregate movement of particle mass associated with a singleperturbation or recovery or a combination of a perturbation andrecovery. The output of the density velocity as defined by the slope ofdensity change may be converted to adjust the R scale from, for example1-15 velocity R (VR), so that the severity of momentum is reasonablycomparable across particle types. One embodiment estimates a densitymomentum associated with the aggregate movement of particle massassociated with a single perturbation or a recovery or a combination ofa perturbation and recovery. The output of the momentum estimation maybe converted to adjust the R scale from, for example 1-15 “momentum R”(MR), so that the severity of momentum is reasonably comparable acrossparticle types. Other converted severity values such as perturbationforce may also be calculated if multiple measurements are made allowingthe detection of acceleration. It may be preferable to use the various Ronly as tools to generate images and not to output or quote R toclinical staff as clinicians may confuse these normalized severitymeasurements with actual density values. The displayed numeric outputsin the organelles are preferably the absolute values of density ordensity change, whereas the color, size, shape, movement, or position,of a given organelle may be a function of one or more R or otherindicator of severity such as relational indicators.

With this approach density changes may be defined as a function of theR. In one embodiment changes in density toward normal are consideredrecovery changes or recovery vectors. These may be quantified asrecoveries and designated with the direction, momentum, and duration ofthe vector. For example a low venous potassium density of 2 meq/100 ccmay be designated with a conversion to 12 DR (as it is a lifethreatening low density) whereas a potassium value of 4 meq/100 cc maybe converted to 0 DR as this value is likely to be phenotypicallynormal. If the potassium moved from 2 meq/100 cc to 4 meq/100 cc in 24hours, the converted perturbation severity may be calculated as 0 PRP asthe movement from 12 DR to 0 DR is not considered a perturbation but israther considered a recovery. In this example the recovery change willbe designated as 12 Recovery R (RR) reflecting excellent recovery from aseverely perturbed density value.

One example of DR and PR designated heuristically. In this example, ifthe potassium was 2 meq/100 cc and then measured 24 hours changed to 5meq/100 cc this may, for example, generate a first venous potassium DRof −12 and a second venous potassium DR of +4. However, the movement ofsuch a large mass of venous potassium into the venous compartment maypose a risk if the force causing the movement remains operative. Howevermovement toward normal carries less risk than movement away from normalso this may be weighted (for example by multiplying a recovery movementby 0.5 or another value as reflected for example in a weighting table).Therefore, the conversion for the above rise event from 2 meq to 5 meqto R would comprise three vectors, two sequential positive R vectors,the recovery R vector and the perturbation (overshoot) R vector, and thevector sum of the two R vectors, all three of these may be described byR values with the third representing a vector sum, the vector sumrepresenting the total movement of particle mass during the sum of theduration of the two vectors. For some particles, anytime the totalchange is high there is reason for concern whereas with others, such asinvasive particles, a fall may only be favorable so that for thisparticle the weighting of the severity of a change may be different fordifferent particles, for example with invasive particles change, theabsolute value of any fall in particle density may always be designatedby RR.

The connections and interrelationships of the forces and the particledensities which comprise the PHM are extensive and the PHM is temporallyand spatially interdependent. For this reason, a local primarydistortion of the PHM often induces secondary distortions of the PHM.These secondary distortions comprise dynamic changes of other particledensities and/or other forces which comprise the PHM. This secondarydistortion may be self-limiting and may be reversed by secondaryrecovery forces or this secondary distortion may induce a tertiarydistortion or a force cascade of PHM distortions which may spread acrossthe PHM and overwhelm even cascading density stabilizing and recoveryforces until these forces are no longer sufficient to return the PHM toa state where sustained life is possible. The PHM now is in a state ofterminal distortion. Terminal distortions are generally initially highlycomplex and may further increase in complexity despite the inability ofthe matrix or healthcare workers acting on the matrix to return thematrix to a state which will remain living very near death and afterdeath the matrix may exhibit a progressive more entropic pattern overtime as life forces progressively diminish to the no life force state.The entropic progression may be more rapid in specific compartments ofhighly complex function and high dependence on high instantaneous oxygendensity, such as the brain, whereas it may be less rapid in compartmentswith less complex function and less dependency on instantaneous oxygendensity.

According to some embodiments, the presence of a density modifying forcein the PHM is identified by identifying a density perturbation of atleast one biologic particle in at least one PHM compartment. The densityperturbation (and the related severity of the perturbation) maycomprise, but is not limited to, at least one of a magnitude, a slope,an acceleration, a pattern, a polarity, a percent change, a frequency,an amplitude, and relational combinations of the preceding variations ofthe same or with other particle densities. Density perturbationscommonly occur as a rise (increasing biologic particle density) or afall (decreasing biologic particle density) or in the alternative aperturbation may comprise a deviation form a normal (phenotypic) patternof a particles density over time. However, two instances of increasingdensity of the same particle, for example, may comprise different typesof events which only share the common feature of comprising a rise inthe same particle density. Since, in one embodiment, as will bediscussed, the processor 200 links perturbation inducing forces withperturbation events, the two instances may not be otherwise related interms of causality. In an example a fall in platelets with a low slopemay be defined by the processor 200 as a different event (rather than aless severe event) from the decrease in platelets with a high slope. Inthis way perturbations of similar polarity but with different patternssuggestive of different causal forces may be readily linked by theprocessor 200 to the forces more likely to have inducing them. In oneembodiment the linkage is of variable strength and based on probabilityof the linkage.

The linkage may be scaled between 0 and 15 with 15 representing thehighest probability of causal linkage. For example a H2CO3 fallassociated with a rising anion gap, and a rising lactate, and a low SVO2provides a linkage of 15 indicating the pattern of forces is sufficientto render a definitive causal diagnosis that these forces caused thenegative perturbation of H2CO3. However, neither a rising anion gap, nora rising lactate, nor a low SVO2, are apical forces which may begin theprocess. In one embodiment the processor 200 is programmed to proceedwith searching and testing until the apical force is identified.

In one embodiment the PHM processor 200 builds the PHM and itsdistortions by linking objects to produce basic relational objects whichmay comprise 2 linked events (binaries), three linked events (trinaries)or four linked events (as coupled binaries or as quaternaries) andbuilds more complex objects (for example force cascades of events orforce cascades of binaries, trinaries or quaternaries) by addingobjects. Binaries include but are not limited to: An image binary may becomprised of, a first event or exogenous action (called an ialpha event)and second event or exogenous action which occurs in relation to theialpha (called an ibeta event).

A perturbation force binary may be comprised of, for example anendogenous force or exogenous action (called a falpha event) whichpotentially induces a perturbation event (called an fbeta event). Thisis contrasted with image binaries which are linked due to theirrelationship in an image or cascade and not necessarily due to aforce-density perturbation relationships.

A recovery force binary may be comprised of, for example an endogenousforce or exogenous action (called an fsigma event) which potentiallyinduces a recovery event (called an ftau event).

In one embodiment, an fbeta cascade comprises a cascade of perturbations(which is the typical early image of a cascade). An ftau cascadecomprises a cascade of recoveries (which is the typical late image of atreated cascade). An fbeta cascade-ftau cascade reciprocation may becomprised of the combination of a perturbation cascade and a recoverycascade. These are the types of incomplete images of distortions whichoften exist before the polyquaternary which defines the identity of thedistortion of the PHM is solved.

One or more variations of falpha may induce or otherwise cause orcontribute to the same type or types of variation or a different type ortypes of variation of the fbeta event. A particle density modificationwhich comprises an fbeta event is often both a threat to the health ofthe human and also a marker which the processor 200 analyses along withother binaries or image components to generate a distortion comprised ofthe falphas and fbetas and to identify to the source(s) of that threat.

Within one compartment of the PHM, such as, for example, venous blood, afirst particle density induced by a first force may comprise a secondforce which alters or tends to alter the density of at least one secondparticle within the same or another compartment. The second densitymodifying force may be induced by the second particle density directlyor indirectly (as, for example, through the action of the particle on anorgan or group of cells which induces the density modifying force). Theprocessor 200 continues to links new forces and densities to generateimages and cascade of linked forces and perturbations. Alternativelydysfunction or failure of an organ or group of cells, and/or theincreased or decreased intake or output of a given particle, maycomprise a first density modifying force without an intermediateparticle.

A first perturbation of particle density responsive to a first force maycomprise a second density modifying force on at least a second particledensity. These events and forces are linked by the processor 200 togenerate cascades of particle density perturbations and the companioncascades of particle density modifying forces which induce theperturbation cascades. These generate apical or primary, secondary,tertiary and cascading distortions of the PHM and of the motion imagesresponsive to or representative of the dynamic distortion.

In one embodiment, a density modifying force is defined as a recovery ifthe direction if the force vector is toward a normal range and as aperturbation of the direction of the vector is away from a normal range.The density modifying force is further defined as positive (and/or theperturbation or recovery is defined as positive), if the particledensity perturbation or recovery responsive to the force comprises arise in density of the perturbed particle. The density modifying forceis defined as negative (and/or the perturbation or recovery is definedas negative), if the particle density perturbation or recovery comprisesa fall in density of the perturbed particle. The density modifying forcemay be a direct force or may be mediated by one or more controllingsensors responding to the perturbation, and/or one or more otherparticle densities or perturbations.

In an example, an alpha (a perturbation force) comprising a rise in thedensity of the molecular particle, H2CO3 in venous blood away from thenormal range, may induce an theta (perturbation event) comprising a risein the density of the gaseous particle CO2 in arterial blood. In anotherexample, an alpha comprised of arise in the density of the particlecortisol (as defined by the administration of the drug or a measureddrug level) may further comprise a positive falpha in relation toparticles glucose, insulin, and neutrophil and a negative falpha inrelation to particles lymphocyte and eosinophil. In a further example anfalpha comprised of the infusion or at least a minimal density of theparticle heparin may further comprise a negative falpha on the particleplatelets in the presence of an falpha comprised of a minimum density ofa companion falpha particle, antiplatelet factor 4.

The processor 200 is programmed to manage exceptions to this approach.For example, during a sepsis cascade, a rise in the density ofneutrophils may peak and then the neutrophils may fall back toward, intoand then below all of the normal ranges. In one embodiment, this isidentified and designated as a bipolar perturbation which is a subclassof a perturbation wherein the positive perturbation force is laterreplaced by a negative perturbation force (in the case of neutrophilcase comprising relative failure of bone marrow production or release)and is divided into two sequential force binaries, a first perturbationbinary and a second negative perturbation binary which is corrected by apositive recovery.

The processor 200 may be programmed to consider a plurality of factorsin discriminating a bipolar force perturbation from a force quaternary.For example, if the processor 200 detects at least one of, parallelperturbations or the slopes of parallel perturbations which have notbecome less severe, the interval after treatment to the onset of thereversal in polarity is insufficient to expect recovery, or a newperturbations suggestive of increasing severity has developed adjacentin time to the reversal, then the processor 200 designates theperturbation as a bimodal perturbation and identifies the second portionof the bimodal perturbation as a second force perturbation having thesame force as the first force perturbation. In the above example if theprocessor 200 detects a rise in neutrophils followed by a fall, theprocessor 200 looks for the forces which induced the rise and the forcewhich induced the fall. The processor 200 also evaluates the parallelperturbations or the lack thereof. If, for example, if the processor 200detects that a negative perturbation of H2CO3, a negative perturbationof platelets, and/or a positive perturbation of heart rate continuewithout reversal of slope or improvement then the processor 200 mayidentify the neutrophil pattern as a potential bimodal perturbation ofneutrophils and then may designate the rise in neutrophils as a firstperturbation and the fall in neutrophils as a second perturbation not arecovery. These two sequential perturbations will have the same falpha(in this case sepsis). However, the processor 200 may seek to identifyanother other force or other forces (other than sepsis) along the PHMwhich may have triggered a fall in neutrophils (such as chemotherapy).

For particle densities which may potentially exhibit a bipolar pattern,for example in response to a common a single force, the designation of arecovery (ftau) by the processor 200, will occur if an antecedent theta(which is at least partially reversed by the ftau) has been detected andno competing perturbation, force which would explain the reversal andsolve the change as a new force perturbation is identified. If no thetahas been detected a change in such a particle is designated as aperturbation.

A recovery may overshoot and this will comprise an overshootperturbation and will be detected by the processor 200 as a continuationof the recovery vector until it turns into a perturbation as it passesthe normal range. A recovery force comprises the perturbation force ofthe overshoot perturbation. One example which may produce a positiveperturbation overshoot is a neutrophil recovery in the above example.

The particle density which induces a perturbation force may be externalto the compartment wherein the perturbation of particle density occurs.A positive or negative perturbation force, or a high or low value ofparticle density, in relation to the patient's phenotypic range (or therelevant population's normal range of a the particle density) indicatesthat one or more forces, which may induce that range of positive ornegative perturbations, has likely occurred.

In one embodiment the processor 200 is programmed to detect aperturbation in density of one particle along the matrix and then todetermine at least one value indicative of the perturbation or one ormore features or measurements of the perturbation (for example a changein density value, density slope, etc.). The processor 200 is programmedto order, detect, and/or quantify the density of other particles and/orto detect a perturbation force or recovery force which would be expectedto induce the perturbation or recovery the at least one value indicativeof the perturbation or recovery. In one embodiment the processor 200builds a time matrix of particle densities, actions, and dysfunctions,objectifies the time matrix, and then identifies the occurrence ofobjects comprising potential perturbation forces by identifying theoccurrence of positive or negative density perturbations or of high orlow density values, and then identifies and/or outputs the potentialperturbation forces as well as the projected forces on other particledensities as well as the matrix or an image representative of thematrix.

In an example, if a positive density perturbation and/or high densityvalue of the particle K+ is identified in the venous blood compartmentof the PHM, then this indicates that a perturbation force has occurredbecause the K+ particle density or at least one feature of theperturbation is outside the range or otherwise is varying in a manner,which would, without the presence of this perturbation force have beenprevented by the density normalizing force that particle. Therecognition by the processor 200 that a density modifying force eitherhas occurred, or is occurring, triggers a search for the perturbationforce which could cause the detected density value or densityperturbation. This force may, for example, be one or more of: an actioncausing an increase in intake of K+, an increase in intake of K+ itself,another particle density which causes a positive change of K+ such as abeta agonist particle or aldosterone antagonist particle, or an organdysfunction such as renal dysfunction (which may, for example, alsoinduce a perturbation force on the particle creatinine so that venouscreatinine density may be used as a marker for the force (for example, apositive perturbation force comprising an increase in the venous densityof creatinine may then comprise the falpha for an beta event comprisinghigh or increasing venous K+ density). The perturbation force binarywould comprise a linked increase in creatinine density and an increasein K+ density. The processor 200 would then search for other potentialfalphas such as the intake of aldosterone antagonists and/or anangiotensin converting enzyme inhibitor, and/or the intake of KCL orother molecules containing K+. The processor 200 will then search forthe one or more fsigmas, (the recovery force(s) which will induce therecovery of the perturbed K+ density), such as, for example thediscontinuation of the angiotensin converting enzyme inhibitor. If nosuitable fsigma is detected, the processor 200 may be programmed withprotocolized order for at least one fsigma and then to detect theoccurrence of the fsigma which was ordered, and to order additionaldiagnostic testing to assure the expected or desired ftau (recovery ofthe venous K+ density occurs) within the specified time interval.

In addition to the sequence above the increase in venous creatininedensity represents both an ialpha and a falpha. In one embodiment fiveor more ranges or relational ranges of density values are stored for aparticle density (such as creatinine) for any given compartment; a firstpopulation range as defined by the relevant general population, a secondphenotypic range, a third personal baseline range as defined by thepatient's baseline values around which is the phenotypic range, a forthrisk range, as defined by that particle density related risk values (ifany) in relation to the PHM, which may include the medications received,the images and or cascades generated by the patient, or the patient'sknown conditions, and a fifth range as defined by a range of preferenceor for some specific purpose by the healthcare worker(s) managing thepatient.

In the instance of creatinine, a positive perturbation of venouscreatinine density outside the patient's phenotypic range comprises antheta for which the processor 200 will search for the falpha which couldhave induced that perturbation in relation to the PHM. The falpha(perturbation force) may comprise a medication, an inflammatory cascade,sepsis cascade, a fall in fluid intake, a fall in cardiac output, toname a few. If a suitable falpha is not identified or if a detectedfsigma (recovery force) fails to reverse the falpha, when reversal wouldbe expected if the falpha was the only force active in relation tocreatinine, then a range of testing for falphas may be ordered by theprocessor 200 as protocolized. In addition, this theta of creatininecomprises a positive sentinel falpha for many other positive particledensity perturbations of, such as medications cleared by the kidney.Furthermore, this theta of creatinine comprises a negative sentinelfalpha for negative particle density perturbations such as H2CO3.

The processor 200 may be programmed to search for, analyze, and linkeach potential theta and to order tests for particle densities which,given other distortions along the PHM, may be affected and to reduceparticle densities (such as drug dosages) which are likely to beaffected. In one embodiment, a perturbation of a single particle density(such as a positive perturbation of venous creatinine density or anegative perturbation of venous platelet density) may trigger a range ofobject linkages extending from the falpha objects generated by processor200 which characterize the positive perturbations. These objects maythen be linked to the theta. The theta will be linked to the fsigma,which will be linked to the ftau. The combinations of these many linkedobjects generate an image and physiologic characterization of the globalimpact on the PHM and in particular on the dynamic patterns and valuesof densities of a wide range of particles in the venous compartment thatan falpha may be inducing (or signaling in the instance of a sentinelfalpha).

Perturbation force binaries may be identified as having a solution ifone or more falphas, which would be expected to induce the perturbationvalues or range, has been identified. Perturbation force binaries areidentified as having no solution if no falphas have been detected whichwould be expected to induce the perturbation values or the range whichhas been detected. Binaries with no solution, comprise for example;perturbations and or high or low density values, without the expectedforces or relational events, perturbation forces without the expectedperturbation, recovery forces without the expected recoveries, andrecoveries without the expected recovery forces. A time matrix or otherrendering of binaries which have a solution may be generated anddisplayed in combination with or separate from the time matrix or otherrendering of binaries without a solution. In one embodiment, a PHM maybe comprised of binaries with and without solutions which may bedifferently designated or displayed.

In an example, a positive perturbation of venous density (or a highvenous density value) of neutrophils may be induced by a range offorces. As noted, the presence of a minimum density of corticosteroidparticles comprises one potential falpha inducing a positiveperturbation of neutrophil density. However, the increase in density ofneutrophils induced by corticosteroids is generally modest andcorticosteroids would not be expected to induce marked increase indensity of band particles. Therefore, a perturbation indicated by amodest increase in the density of neutrophils (a first theta event)would have one solution identified if corticosteroid administration isidentified as an falpha event by the processor 200. However, if apositive perturbation in temperature (a second theta event) and apositive density perturbation theta in band particles 9 a third thetaevent) is identified, the forces inducing these two fbetas cannot besolved by a corticosteroid falpha. Furthermore, since the three fbetasare all potentially relational (relate to a common falpha), thecorticosteroids are designated by the processor 200 as an unsolvedperturbation force binary for the relational binary wherein the theta isa complex object comprised of a combination of the three related fbetas.In one embodiment, the processor 200 is programmed to output thepresence of two perturbation force binaries with no solution and a thirdperturbation force binary with a solution. The processor 200 may thenoutput a visual indication of all three thetas and variations of therelational pattern of all three thetas (as derived from the increase invenous neutrophil density, increase in temperature, and increase indensity of band particles) along with the designation that the falphafor these thetas and particularly for the combination of these thetas(when grouped as a single theta object) has not been identified.

In one embodiment all elements that have a potential to form anybinaries—exogenous events, occurrences, patterns, and forces to name afew—are continuously monitored (e.g. searched for) such that the absenceof an element, after a sufficient processing delay or cycle indication,may be recognized as a failure of identification for a given time span,and therefore may indicate a binary without a solution.

Overlapping dynamic visualizations such as weather maps responsive tobinaries with solutions and without solutions may be generated. In oneembodiment annotations or other indications are provided which mayindicate that a patient storm cell or group of patient storm cells doesnot have a solution and the falpha (and particularly the apical falpha)inducing the storm cells is unknown.

In one embodiment, the processor 200 is programmed to display whichbinaries have complete solutions and which do not. Overlapping weathermaps responsive to binaries with solutions and binaries without solutionmay be generated. In one embodiment annotations or other indications areprovided which indicate that a patient storm cell or group of patientstorm cells does not have a solution (and the forces or inducing thepatient storm cell is not yet known).

The unsolved falphas and fsigmas may be mapped on a time matrix inrelation to the position of associated positive and/or negative densityperturbations (and/or high or low density values) and recoveries whichindicated the presence of the undetected forces. A large or expandingmatrix of many binaries with no solution may be indicative of diagnosticdelay (for example, caused by inadequate protocol, a breakdown inprotocol, inaccurate diagnoses to name a few). The processor 200 may beprogrammed to quantify the number of individual and relational binarieswhich do not have a solution and to provide an output indicative ofunsolved forces per unit time.

Early in the presentation of the patient, there may be many binarieswithout a solution. As time progresses, the number should progressivelyreduce. A graphical representation of the number of unsolved binariesmay be presented to QA personnel and protocol violations may beindicated. At discharge, binaries without a solution which remain may beoutputted by the processor 200 along with orders or recommendations forsolving the binaries if warranted. The identification and quantificationof density perturbation forces according to some embodiments providesmore sensitivity to residual and dynamic diagnostic deficiency then theconventional identification of abnormal laboratory or vitals values atdischarge.

In one embodiment the processor 200 is programmed to differentiate inthe display image binaries (which represent image components) from forcebinaries (which, in addition to representing image components may alsobe defined by the density modifying force exerted by the falpha on thetheta or by the fsigma on the ftau). The display of the force binariesas overlays, or in-combination with the image binaries may be provided.The forces or the force binaries may be presented as a semi-transparentoverlay.

The physician may have the option, as by right clicking on the displayeddensity modifying force or force binary of the PHM or on the displaysuch as a weather pattern produced by the density modifying force orforce binary, to identify or select the falpha and particularly theapical falpha likely inducing weather patterns or to select an action,such as testing, to identify the falpha. At the time of patientdischarge a relational timed display and/or listing of the residualbinaries without a solution may be provided. The physician may thenselect the falphas likely inducing the perturbations detected by theprocessor 200. Since, with more data and time, the processor 200 mayidentify the falphas and thereby find the solution for these binaries,additional information and further processing after discharge maydisclose whether or not the physician's designations were correct. Theprocessor 200 may be programmed to provide a context sensitive group oftesting choices (as from a drop down menu) known to potentially identifyone or more falphas which could have induced the detected theta.

The processor 200 may be programmed to automatically order futuretesting to determine the future of the falpha, or may be programmed toprovide an option for the physician to instruct the processor 200 toignore one or more of the forces. In one example, when there issufficient time, without undue risk of diagnostic delay, to performtests in sequence, the processor 200 may process a risk cost basedanalysis to determine the next tests to be performed. For example theprocessor 200 may rate the probability that the test will identify thefalpha, rate the potential risk of the test, rate the risk of failure toperform the test, and rate the cost of the test. The processor 200 maybe programmed to rate the risk of the test from 1 to 5 with 1 being thelowest risk, the risk of failure to rapidly diagnose rated from negative1-negative 5 with the lowest risk being negative 1, the probability thatthe test will identify the falpha may be rated from 1-5 with the highestprobability being 1, and the cost of the test from 1-5 with the highestcost being 1. The risk of the test or the risk of failure to rapidlydiagnose may be weighted to provide 2-3 times its value. Alternativelyanother factor may be weighted. The test selected to order first may bethe one with the lowest sum. (Alternatively non-invasive and minimal ornon-irradiating tests may be prioritized and quantified separately frominvasive tests because to place the do-no-harm doctrine as a primeobjective.)

In an example a negative perturbation of venous platelet density isidentified by the processor 200 along the PHM as a 10% decline inplatelets over 24 hours with a fall slope of 5/6 per hour and anabsolute fall of 20 from 200 to 180. The processor 200 searches for anfalpha, for example, prior infusion of heparin, inflammatoryaugmentation, recent transfusion, recent treatment with clopidogrel,positive antinuclear antibody, to name a few and searches for otherpotential falpha or sentinel falpha along the PHM (which may include forexample prior infusion of heparin and/or an evolving sepsis cascade). Ifthe processor 200 identifies heparin infusion within the appropriatetime, the processor 200 may be programmed to proceed with testing as afunction of a threshold or a derivative of the combinations of thenumbers or based on a pattern of the time series of the sum or aderivative of the combination of the numbers. For example the processor200 may be programmed to proceed with ordering a test if the sum is lessthan 5. Platelet factor 4 is an expensive test which may be rated a 4 interms of cost, but it is a simple blood test it has a low risk which maybe rated as 1 in terms of risk. However, the risk of failure todiagnosis heparin induced thrombocytopenia is high but, if present, itis still very early so this may be rated as only negative 3 and finallythe probability the test will be positive is low given the marginaldecrease in platelets and brief decline so this may be rated as 5. Thesum is 7, which is above the threshold so the processor 200 will notorder the test unless overridden. The processor 200 may be programmed tocalculate the time, as projected by the slope, wherein the sum would be5 if the slope of the decline continued and to repeat the platelet countat that time and make another programmed decision about which tests toorder (if any). These ratings may be heuristically derived by expertpanels and then readjusted as determined by assessment of cost andperformance associated with the ratings.

Even seemingly minor density modifying forces may be deadly because theymay irreversibly distort the PHM. This is especially true if the forcescontinue unabated or progressively increase (as may be the case when aself-replicating microbe has invaded the human, distorting the PHM).Often only a few organisms initially invade the PHM and produce minimaldistortion of the PHM. Distortion of the defense (immune) system of thePHM often comprise the first fbetas and falphas which are readilydetectable when the numbers of organism which have invaded the PHM isstill too low for detection even by blood polymerase chain reactiontesting. Here it is the dynamic distortion of the PHM, and not anysingle or relational density value, which best characterizes the stateand cause of invasion. As the organisms increase in numbers, the PHMdistortion they induce in the immune system increases and the invasiveproteins generated by the organism may induce PHM distortion, forexample in the clotting system. Each distortion in this comprehensivelyconnected PHM pulls or pushes on another portion of the PHM dynamicallydistorting that portion. Each time a distortion occurs in the PHM,dynamic compensatory perturbation forces may be triggered to protect thePHM. In addition dynamic recovery forces may also be triggered to movethe PHM into a more life favorable matrix configuration which may not bethe original configuration of the PHM. Compensating forces, whileresponsive to perturbations are different from recoveries in that theywill not mitigate the falpha but are rather temporizing and often simplymitigate the fbeta producing a false sense of recovery. In oneembodiment, compensating forces and compensating events comprisecompanion falpha and fbeta to the perturbation being compensated. Theseverity vector of the compensation fbeta may be combined by theprocessor 200 with the severity vector of the primary perturbation fbetato reveal the actual severity induced by the combined perturbation andcompensating perturbation.

Upon detection of early distortion of the PHM, the risk of excessive orirreversible distortion of the PHM posed by one or more perturbationforces (such as that induced by invasive bacteria) may be reduced byempiric treatment in programmed response to one or more fbetas and/orfalphas or larger pattern along the PHM. In one embodiment, perturbationforce binaries have four basic states presented in order of increasingrisk; solved and falpha and/or fbeta treated, unsolved but potentialfalpha and/or fbeta empirically treated (as by processor ordered andprocessor confirmed treatment), unsolved and potential falpha and/orfbeta untreated, solved but falpha and/or fbeta untreated. The last tworisk categories may pose an equivalent risk.

The processor 200 may be programmed to detect a new increase in binarieswithout a solution and identify as by display when an increase and/or acascading matrix of such binaries occurs and to indicate the presence ofthe development of a new undiagnosed condition or complication and tosuggest or automatically order testing in search of the missing binarycomponents which may provide the solutions for the binaries. Binaries orcascades of such binaries without a solution may be severity indexedbased on the potential risk associated with the binaries and the indexoutputted.

In an example, a negative perturbation of the density of venous H2CO3 incombination with a preceding positive density perturbation of venousbands, a subsequent negative perturbation of the density of venousplatelets, may be displayed on the PHM as either as a grouping ofperturbation image binaries, perturbation force binaries, or both. Thisgrouping of binaries, if unsolved and not empirically treated, has ahigh severity risk indicating that a rapid solution comprisingdetermination of the falphas (one of which may be sepsis) is mandated.With these binaries and the cascade distorting the PHM, the risk offailure to rapidly diagnose is high, for this reason the processor 200is programmed so many tests will be immediately ordered by the processor200.

Domain of Sets of Biologic Particle Densities of Living Human Beings

A formal domain exits which comprises measurements of compartmentalizedbiologic particle densities in human beings. This is a primary domain inthe field of medical diagnostics. However, data sets of this domaingenerally lack formal objective mathematical solutions so that largesets of data (such as those in the cloud or on hospital servers),existing with little or no mathematical solution, is a normal finalstate of data for this domain. For a typical data set in this domain,the lack of a mathematical solution is supplemented by subjectivesolutions to render highly variable diagnostic results. This renders adomain wherein: a perpetual state of even a large data set with littleor no mathematical solution is typical; simple data points existing as“numbers on a page” are acceptable final data formats; and incompletedata sets commonly exist without being so identified.

This explains the crisis which exits in this domain. There is a need todefine a formal mathematical solution for data sets in this domain.

Axioms of the Domain of Sets of Biologic Particle Densities of LivingHuman Beings

Given a biologic particle density set D of a living human there exists aforce set F, whose members induced exactly those members of D.

Given a biologic particle density set D there exists a probabilisticforce set P(F), whose members have a probability >0 of having inducedexactly those members of D.

Given a collection of biologic particle density sets there exists anormal set N, whose members are exactly within a phenotypically normalrange.

Given a normal set N there exists a normal force set F_(n), whosemembers induced exactly those members of N.

Given a normal set N, there exists a probabilistic force set P(F_(n)),whose members have a probability >0 of having induced exactly thosemembers of N.

Given a collection of biologic particle density sets of a living humanthere exists a perturbed set P, whose members are not the same as themembers of set N.

Given a perturbation set P there exists a variation force set F_(v),whose members induced exactly those members of P.

Given a perturbation set P there exists a probabilistic variation forceset P(F_(v)), whose members have a probability >0 of having inducedexactly those members of P.

Given a collection of density sets of biologic particle density sets ofa living human there exists a recovery set R, whose members are not thesame as the either the members of set N or the members of set P.

Given a recovery set R there exists a recovery force set F_(r), whosemembers induced exactly those members of R.

Given a recovery set R, there exists a probabilistic recovery force setP(F_(r)), whose members have a probability >0 of having induced exactlythose members of R.

According to one embodiment, this set of axioms, analysis may proceedwith standard mathematical methods of reduction, inference,simplification and synthesis to engage the science of human medicaldiagnosis through application to the parallel human time matrix.

In an embodiment, a display is provided indicative of a PHM comprised ofsolved perturbation image binaries; recovery image binaries,perturbation force binaries, and recovery force binaries, as well asunsolved binaries. Compensating image or force perturbation binaries,which may comprise a sub class of perturbation binaries, may also beuniquely designated in the display so that the severity of compensatoryperturbation force and/or compensatory perturbation may be readilyvisualized. Since in response to severe r progressive perturbations,compensation is often limited in severity and time the processor 200 mayshow a display indicative of the severity of compensatory perturbationin relation to its projected limits. Binaries and/or the graphicalrepresentations derived from them (such as weather map type images) mayhave a different colors, or other markings to differentiate differentbinaries and between solved and unsolved binaries or the storm cellsassociated with different binaries.

While the ialpha of an image binary is not generally a medical condition(although it may be), at least one falpha of a force binary is often amedical diagnosis. A plurality of force binaries may be generated withthe same falpha or the same theta. For example, one perturbation forcebinary may have a theta comprising an increased density of lactate inthe venous compartment and/or metabolic region of the PHM and its falphacomprising the diagnosis of sepsis, while a second perturbation forcebinary may be comprised of the same increased density of lactate butwith an falpha comprising a decreased density of central venous oxygen,while a third perturbation force binary may be again comprised of thesame increased density of lactate but with an falpha comprising adecreased cardiac output. The decreased cardiac output may also be thefalpha for the theta comprising the aforementioned decrease in densityof central venous oxygen. Furthermore a decrease in density of venousH2CO3 may be the theta for the three falpha comprised of; increaseddensity of lactate, the decrease in density of central venous oxygen andthe decrease in cardiac output. Finally the low central venous oxygendensity may be an theta for the decrease in cardiac output. A lowvascular volume may be one falpha for the theta which comprises adecrease in cardiac output and sepsis may be another falpha for thatsame theta. Finally active sepsis may be an falpha of perturbation forcebinaries for each of these fbetas. In this way, an embodiment generatescascades of perturbation force binaries comprising falphas (forceinducers) and fbetas (for example particle density changes) responsiveto the force inducers.

These linked sequences and cascades of binaries define the mechanismsand physiologic basis for the operative pathologic process and source ofthe primary distortion of the PHM, which for example with sepsis as anapical falpha comprises the common or global falpha for the entireperturbation force cascade. However although sepsis may be designated asan apical falpha, sepsis cannot comprise a completed proximal end of acascade. The cause of the sepsis (the triggering event, the invasiveorganism, and the primary and secondary compartments invaded) are allpotential proximal falphas for systemic sepsis which need to be solvedfor the binary which contains sepsis as the theta to have a designatedsolution by the processor 200.

The processor 200 is programmed to follow the cascade back in time toits origin to detect the apical falpha and also the actions (such ascentral line insertion or surgery which may have triggered the apicalfalpha.

In one embodiment a single diagnosis (such as active sepsis) maycomprise an apical falpha for each component of a perturbation forcebinary cascade and a single treatment, such as penicillin infusion maycomprise an apical fsigma for each component of the subsequent recoveryforce cascade. Many other falphas will also be identified for smallerpatterns of fbetas or for individual fbetas.

Many diagnoses which comprise active disease have companion eventsembedded within the PHM, which related to treatment or to anothercondition or sprigs of early recovery from another condition. In anexample, perturbations which would not be expected to be induced by theforce of active sepsis (such as a sever fall in density of venouspotassium) will not, if detected, be included in the cascade ofperturbation force binaries having an falpha of active sepsis anddespite the detection of a massive sepsis cascade, the processor 200will search for another falpha to explain the severe fall in density ofvenous potassium. The detected falpha may be, for example, theadministration of furosemide anther force.

In one embodiment all particle densities are designated as falling intoat least a portion of the following categories; particle density innormal population range, particle density in the phenotypic range forthe patient, particle density chronically stable and elevated ordecreased in relation to phenotypic range, particle density chronicallychanging and elevated or decreased in relation to phenotypic range,particle density high or low in relation to phenotypic range butstability is unknown, particle density acutely increasing or decreasing.Any of these may be identified by the processor 200 as ibetas or fbetas.In this way the processor 200 tracks all densities and densityvariations, establishes the phenotypic density range or another rangefor each patient and determines when the densities have been perturbedand searches for one or more falphas which may have induced thatperturbation. The processor 200 may generate outputs for healthcareworkers wherein all densities have the above designations and densitieswhich are not stable are flagged and automatically tracked by testing.The timing of testing may be, for example, defined by the rate of changeand/or the falpha (if known), or by other healthcare worker orstatistically testing defined protocols. The above categorization ofbetas and testing protocols, according to some embodiments, provides amechanism to prevent density changes from proceeding without, at least,process based analysis of that density change and healthcare workernotification, if indicated.

In one embodiment, the healthcare worker may choose to visualize atleast one time segment of the PHM in a format such as a color radarweather map as derived from solved and/or unsolved perturbation imagebinaries, recovery image binaries, perturbation force binaries, and/orrecovery force. Drill downs requesting the binary information relatingto the patient storm cells may reveal the spatial and temporal patternrelationships of both density modifying forces and density changes.Drill downs, as by touching a storm cell, or passing a pointer or mouseover a storm cell requesting the image binary information relating tothe patient storm cells may reveal the spatial and temporal patternrelationships of events, patterns and cascades comprising the image of apatient's condition and care.

Perturbation of the phenotypic dynamic relational range and/or a patternof densities may also comprise an theta or ibeta and a force modifyingone or more components of the dynamic relational range or pattern ofdensities may be a falpha producing a perturbation force binary of thedynamic relational density range or density pattern.

In one embodiment, other events other than values or perturbations ofparticle densities may be included as fbetas or ibetas of the PHM. Forexample the frequency or consistency of bowel movements may be enteredas by subjective assessment by a nurse or by sensor on the toilet whichautomatically detects bowel movement frequency and/or consistency. Ifdiarrhea is identified by the nurse or detected by the sensor thisbecomes the theta and the processor 200 searches for an falpha. If, forexample, recent prior or present cephalosporin administration isdetected along the PHM this may trigger an order for example Clostridiumdifficile testing on the stool by polymerase chain reaction. If thistesting is positive then both the cephalosporin and the clostridiumdifficile becomes the falphas for the theta diarrhea. Together theycomprise two perturbation force binaries as the cephalosporin willbecome the falpha for the theta comprising a minimum particle density ofclostridium difficile in the large bowel compartment. The PHM processor200 may be programmed to check the PHM for allergies and order treatmentif protocolized to do so, which may include discontinuation of thecephalosporin or substitution with another antibiotic if the PHMsuggests incompletely treated infection requiring continued antibiotics.The perturbation force binary now has a solution and both the theta andfalpha of the binary are under treatment. The processor 200 will thensearch for recovery of the fbetas (for example recovery of the diarrhea,and a fall of in Clostridium difficile in the stool).

If despite the fsigma, which may comprise the administration ofvancomycin, discontinuation of the cephalosporin and/or other recoveryinducing force, the ftau is not detected (recovery does not occur withinthe expected time) then the recovery force binary is considered unsolvedand the perturbation force binary is designated as a perturbation forcebinary with recovery failure. Processor 200 identification ofperturbation force binaries with recovery failure generates an outputindicative of recovery failure despite treatment for the healthcareworkers.

In another example, an increase in venous density (for example form zerodensity) of chemotherapy as indicated by chemotherapy infusion may bedesignated as an falpha. If the chemotherapy is known to bemyelosuppressive one expected theta of a perturbation force binary mayinclude a decrease in density of neutrophils over a time periodfollowing the chemotherapy. The processor 200 projects the expectedrange of values and slope of the theta over time as for exampledetermined by population studies. A change in neutrophil density and aslope of the change falling within this range comprises a solvedperturbation force binary whereas a neutrophil density change or lackthereof or slope which is out of this range comprises an unsolved orincompletely solved perturbation force binary. The incompleteperturbation force binary then becomes the theta for which the processor200 may be programmed to detect the falphas by ordering additional ormore frequent testing or other diagnostic or therapeutic action, such asblood or fluid polymerase chain reaction testing, blood cultures, and/orthe administration of granulocyte growth factors provided the processoridentifies no contraindication. In this manner all chemotherapeuticadministration events are processed to assure that the perturbationforce binaries are promptly solved and recovery detected and assured, ifpossible.

In another similar example, a surgical procedure may comprise an falpha,which is expected to produce a range of thetas including, for example, amodest increase in venous density of neutrophils and a decrease invenous density of lymphocytes or of one group of lymphocytes such as Thelper lymphocytes (as for example determined by population studies forthat surgical procedure). The processor 200 projects the expected rangeof values and slope of the thetas over time as for example determined bypopulation studies. A rise in venous neutrophil and a fall in lymphocytedensity and slopes of rise and fall within the expected ranges comprisessolved perturbation force binaries whereas a neutrophil density changeor lymphocyte change or slopes which is out of this range, comprises anunsolved or incompletely solved perturbation force binary.

Likewise after surgery a segment of the PHM with a change in the densityof bands outside the expect range comprises an unsolved or incompletelysolved perturbation force binary. The presence of one or more unsolvedperturbation force binaries may comprise new falphas which triggeradditional or more fbetas and falphas such as testing or otherdiagnostic or therapeutic action, such as polymerase chain reactiontesting, blood cultures, and/or empiric antibiotic therapy. The binarylinkages are continued until the recovery force binaries are solved orotherwise resolved along the post-surgical segment of the PHM.

In one embodiment one or more human genes, gene variations, or mutationsmay comprise the falpha (the force inducer) for a given particle densityor relational density change. The identification of a density which isoutside or nearly outside the statistical range identified for therelevant population or demonstrating a dynamic particle density responseto a force (such as the venous density of a pharmaceutical) which isoutside the range which is expected statistically in response to thatforce may generate a review a comparison with the genetic code of thepatient.

In one embodiment the PHM processor 200 is applied to test therelationship of a wide range of human genes to the resting particledensities and/or particle density variations in response to at least oneforce. Each gene (which may be a mutated gene) may be the equivalent ofa fixed step function on the matrix as for example is the genetic sex ofthe patient. Perturbation force binaries wherein theta are at least oneof density values, density variations, relational densities, or cascadesof density variations, are combined with each known gene of the patientas the falpha to produce hybrid force binaries containing geneticinformation. The hybrid force binaries may then be statisticallyevaluated to determine if specific genes or clustering of genes areassociated with one or more specific perturbation force binaries, one ormore density modifying forces, or one or more thetas.

In one embodiment when multiple perturbation force binaries areidentified with a single theta instance the processor 200 may aggregatethe forces to determine whether a possible complete or partial solutionhas been identified.

In one embodiment, the health care worker may be provided with anenvironment to explore “what if” scenarios to examine what conditionsmay adequately solve the perturbation force binaries present. In thisway, the health care worker may narrow proposed solutions even beforelab results have been returned. For example, a health care worker maybelieve that a force would solve a binary but not realize that theseverity of the theta cannot be adequately explained by the proposedfalpha. In this way, simplistic or inadequate explanations which may,without an environment containing the rigor of force aggregation andprojection, have been considered possible answers can, through theapplication of the PHM be quickly ruled out or considered suspect.

In one embodiment, the solution of the force binary is designated as afunction which compares properties of the falpha or fsigma to propertiesof the theta or ftau in, for example, a ratio. For example, the slope ofthe theta may be defined in relationship to the magnitude of the falpha.In the case in which the falpha is a diagnosis, ranges may be providedfor the severity of the diagnosis in a manner discussed previously forforces perturbations and recoveries.

Organ or cellular failure may first induce a density modifying force ona passive (non or minimally force inducing) particle which providesindication of the organ dysfunction or failure and may therefore bedesignated as a sentinel falpha. Perturbation of the density of asentinel falpha indicates that a density modifying force is likely beinggenerated (or may be generated in the future) on at least one otherparticle density.

In one embodiment, the time relationship between the falpha and thetheta may include a phase shift based on presentation delay. If themechanism of acquiring the density values includes a delay, this delaymay be included in the time relationship and may even include thepossibility that the theta may be identified before the falpha presentsto the system.

According to some embodiments, the value of a test, such as a measure ofa compartmental density of a biologic particle, as an “enhancer” of theprobability that a given clinical condition is present, is a function ofthe effect the incorporation of the test into the PHM has on theprobability of the PHM for that condition at the time of incorporation.In other words, the sensitivity and specificity of a measured biologicparticle density for a condition, such as sepsis, is a function of thesensitivity and specificity of the PHM which incorporates the particledensity measure, minus the sensitivity and specificity of the PHM whenthe has not been so incorporated. Using the PHM, the value of adiagnostic test is defined by its ability to more completely fill in themissing components of the dynamic PHM image so that the image is moresensitive and/or specific for a clinical condition than was the originalimage which did not incorporate the test.

In one embodiment the PHM includes a probability matrix as one of itscomponents which may be integrated with the other components of the PHM.The probability matrix comprises a matrix of time series wherein eachtimes series is comprised of the timed probabilities of a condition (forexample sepsis) as defined by the PHM (including the other probabilitytime series).

The time series matrix of probabilities, correlation, and/or probabilitydiscriminating measure (such as sensitivity and/or specificity) ispreferably objectified and analyzed to define probability perturbations(theta) and to identify the forces (falpha) inducing those perturbationsof probability (such as a diagnostic test result, historical or physicalfinding). For example, the processor 200 identifies a 30% increase inspecificity of a time segment PHM for sepsis after a high density ofprocalcitonin has been added to the PHM, in this case procalcitonin isidentified as the force (the falpha) inducing the positive perturbation(the (beta) along the sepsis probability time series of the PHM. Apositive polymerase chain reaction test for bacterial DNA in venousblood may be a very strong falpha inducing a positive perturbation inthe objectified sepsis probability time-series of the PHM sufficient toalter treatment and testing.

According to one embodiment of a method of some embodiments, clinicaltrials to determine at least one diagnostic probability ordiscriminating measure (such as sensitivity and/or specificity) forexample, of a new test are performed using the PHM. One method forevaluating the at least one value indicative of the diagnosticdiscriminating value of a diagnostic test comprises; obtaining medicaldata, which may include for example, genetic, historical, or testderived data, from a set of patients, generating a PHM for each patientderived from the medical data, determining a first result comprised ofthe probability or discriminating measure of a condition using a PHMwhich does not incorporate the result of the diagnostic test,incorporating the result of the diagnostic test into the PHM,determining a second result comprised of the probability ordiscriminating measure of a condition using the PHM having thediagnostic test incorporated into the PHM, comparing the first result tothe second result and calculating a comparison result and defining atleast one diagnostic probability or discriminating measure as a functionof the comparison result. The comparison result may for example bederived by subtracting the first result for the second result.

After a biologic particle has been sampled its probabilistic valuebegins to move away from the sample value and defines a probabilisticrange of values which may be considered a probabilistic wave function ofthe particle. The distance between the sampled value and theprobabilistic range of values after a given time interval will beaffected by the clinical condition of the patient.

One approach for projecting a path of the PHM and particularly the pathof a distortion in the PHM and for determine a patient specificfrequency of automatically ordered lab testing is to calculate apotential worst case path or value of a parameter and then identify theretesting time based on the minimum change of the parameter which wouldhave clinical relevance given the potential condition or conditionsidentified by the processor 200. For example, if the processor 200 hasidentified severe sepsis as a potential condition, then a projectedbicarbonate (or other lab values) may be calculated by Equation 1:

V _(p) =V _(s) +T _(D)(dV/t)+T _(i)(dV/t)  Eq(1)

Where:

-   -   V_(p) is the projected value of the parameter at the projected        time;    -   T_(i) is the time interval between the last sampling time and        the projected time;    -   T_(D) is the delay between the sampling time and the display        time;    -   V_(s) is the value of the parameter at the sampling time (this        may not be known until later if there is a transport and/or        testing delay); and    -   _(d)V_(/)t is the worst case or near worst case slope of the        parameter given the condition(s) identified as potentially        present by the processor 200 (such as sepsis).

An efficient timing of retesting which would enhances the ability toearly detect change may be made by setting the next sampling time to aninterval calculated from specifying the minimum or maximum (depending onthe polarity of the trajectory) of the projected value which would (ifknown) affect diagnostic or therapeutic action given the condition(s)identified as potentially present by the processor 200. For example,suppose the bicarbonate value at the sampling time (Vs) was 20 and isidentified by the processor 200 as falling at a rate of 0.5 meq/hour andthe processor 200 further identified the image as representing a highprobability that sepsis is present, yet the processor 200 identifies thenext test for bicarbonate has been ordered by the physician at 8 hoursand the average, worst 10 percentile (or other measure), of delay fromsampling time to display time (TD) is known or calculated to be 1 hourfor this particular hospital ward. Then in one embodiment the processor200 may be programmed to identify an improved sampling interval based ona projected “near worst case” bicarbonate fall of 1 meq/hour for thecondition of sepsis, and adjust the repeat bicarbonate testing to 2hours since a fall in bicarbonate to 17 (the value which couldreasonably be present in 3 hours (sampling interval plus delay interval)would (if known) affect diagnostic or therapeutic action given thecondition(s) identified as potentially present by the processor 200 (inthis case sepsis). In the alternative, when managing this patientwithout the processor 200 intervention of some embodiments, thebicarbonate could have fallen to 11 (before outputted as 12 on thedisplay) and this value in this range may result in death (perhapsbefore the sample is even taken). As demonstrated in this example, thecondition or pattern specific projection of individual parameter valuesprovides both warning and a means to improve sampling time and thereforethe diagnostic utility of the motion image and improved protocolizationof treatment. Furthermore the projection of multiple parameters may beused to render one or more possible paths which the patient storm maytake if, for example, intervention in not provided.

The processor 200 may be further programmed to, based on the diagnosedclinical condition, or a distortion along the PHM, calculate or projecta potential path range of the first particle density, and then calculateor project at least one other path range of at least a second particledensity based on the first particle path and the clinical condition andor distortion. The processor 200 may project or calculate a cascade ofpaths based on the first particle path and the clinical condition and ordistortion. The processor 200 may be programmed to generate a colorrendering of an image of the matrix and to project the path as a colorrendering. The rendering may have an appearance of radar weather displayand the path may be projected as a color rendering, which may be a timelapsable motion image having an appearance of a path of weatherprogression over time.

In an example, based on the projections for H2CO3 provided in the aboveexample, in a patient with sepsis, the processor 200 may project a H2CO3of 12 in 12 given a projected fall rate of based on the present rate offall and a value of 12 in 6 hours based on a “near worst case” fallrate. The projected respiratory rate when the H2CO3 is 12 likely exceeds30. Therefore a rate range may be projected by placing the rate at 30-36in 12 hours for a present rate based display and at 30-36 in 6 hours andthe paths connected back by the processor 200 to the instant respiratoryrate on the display. A similar approach may be taken for heart ratewhich would be projected in an individual less than 60 without heartdisease or beta blocker to be about 130-140 when the H2CO3 is 12. Theseprojections need not be precise as they are presented to warn of thelikely dynamic consequence associated inaction in the face of thisprojected perturbation in particle density and to teach the physician tothink of the projected future based on the dynamics of the particles inthe present and the disease or disorder present.

The processor 200 may be programmed to project the time range of arrestor intubation based on these parameters. Similar projections may be madefor example the anion gap anion may be projected and the dyspnea index.

In one embodiment the efficiency of testing is quantified. In oneembodiment the pattern of testing is analyzed to determine the patternof testing and the pattern of testing is analyzed to determine thecorrectness, timeliness, and the efficiency of testing. The pattern oftesting includes, for example the distribution and timed frequency of asingle type of test, or all tests, particularly in relation to aclinical condition such as sepsis. According to one aspect of someembodiments, the processor 200 identifies the pattern of distribution oftesting for sepsis. Patterns of sepsis diagnosis associated with afavorable outcome are then compared to identify the most efficientpatterns such as a pattern which demonstrates a high frequency of testsearly along the sepsis pattern or a pattern which comprise a hightesting frequency maintained until the onset of recovery has beenidentified or a decision to reduce care due to futility or familypreference has been specified.

One processing method for optimizing the detection of sepsis comprises,generating a distribution of testing in relation to time and/or at leasta portion of the image of the sepsis, comparing the distribution todestitutions of testing associated with a favorable outcome, comparingthe cost of testing, identifying at least one testing distribution forsepsis, which has a favorable cost and outcome. The method may comparethe distribution of the number of tests per unit time and thedistributions of each type of group of tests per unit time in relationto the onset of the sepsis pattern or another aspect or portion of thesepsis image.

In one embodiment the relationship between binaries, and in particular,falphas and their fbetas are non-consuming. In other words, theprocessor 200 creates binaries of all possible connections rather thanthe first or a statistically preferred connection. Once all possibleconnections are created (i.e. those that meet the criteria as specified)then the processor 200 may further characterize the set of possiblefalphas per fbeta to indicate a continuum of probabilities per binaryidentified. This continuum may be constructed using the probabilitymatrix as described above as well as other mechanisms of proximity,similarity of severity to name a few. Further, the PHM processor 200,once a non-consuming pass has been accomplished, may include a secondconsuming pass in which at least one “best fit” models is proposed. Inone embodiment, the healthcare worker is provided with an environment inwhich a set of “best fit” models are presented. The healthcare workermay interact with the models through gestures using a mouse, touchsurface, keyboard, and/or natural interface to name a few. For example,the healthcare worker may identify links to be “suspect” or otherwiseunlikely. As well, the healthcare worker may indicate a link as “highlylikely” or otherwise indicated as preferred. The processor 200continuously processes the “best fit” algorithms given the new weightsprovided by the healthcare worker. Outputs of the “best fit” modelswould provide transparency indicating the alternatives that wererejected as well as the results of the healthcare worker gestures whichwere included in the weighting of diagnostic options.

In an alternative embodiment, the healthcare worker and/or student isprovided with an environment presenting the model with no forcedesignations, or only very low level force designations. The healthcareworker and/or student may then “solve” the model by selecting forcesthat satisfy the extant occurrences. One or more diagnosis may be addedat a specific point in time to indicate the apical force.

In one embodiment, a perturbation (and/or a force, recovery, binary,quaternary or polyquaternary) is programmed to be aware of its state asa solved or unsolved perturbation and to have a “seeking state” whereinit seeks its binary and quaternary links. The seeking state may bedefined by game theory and the strength of the seeking may be defined bythe type of perturbation and the potential time dependency and severityof the risk associated with the potential solutions. As other seekingperturbations find their forces and recoveries, the new binaries orquaternaries become potential matches for the seeking perturbation. Theseeking state may continue after one or more solutions. The seeking andself-solving binaries and quaternaries and manual, semi-manual, orautomatic distortion building also provides an education function. Thiseducation may be provided as a video game for dynamically building PHMdistortions (for example fbeta cascades or polyquaternaries) andrendering a diagnosis and treatment as a function of the building. Withthis game, the student is learning a new science of computer assisteddynamic relational diagnostics.

In one example of such a video game, the student is first presented withan PHM to review for a time interval, the PHM provides a history bygoing back in time along the PHM or viewing historical segments whichmay be compressed or time-lapsed and by reading the linked narratives orattached digital files. For those who may be inclined, the PHM may alsobe viewed as a naked objectified matrix (as for example in FIG. 6), withthe forces, perturbations, and recoveries, and their features identifiedand color coded for severity. The student may use supplemental viewerspresenting for example weather maps or other dynamic views, examine theraw data in tabular form or as manipulate able time series matrices.

After preparing, the student is then shown the PHM with a dynamicdistortion (which may change more quickly that the real distortion)emerging which will generally be comprised of only perturbations such asparticle density perturbations. The student can link a sufficientportion of the perturbations and recoveries if any for the student toidentify a disease or disorder which likely as induced thepolyquaternary. The student is expected, upon seeing the primers, torecognize the need for other tests, order them, and link the new testresults in the PHM to grow the distortion (for example thepolyquaternary). The distortion (and the polyquaternary if the entiredistortion is being built) at this time will be incomplete and comprisedprimarily of linked perturbations. The student is then expected to solvethe polyquaternary (the distortion of the PHM), by for example insertingthe correct apical falpha which comprises the final diagnostic step inthe solution and the insert the correct treatment falpha, which maycomprise the final solution step. Upon insertion of the treatment, thegame may then insert a range of other forces along the distortion andpresent a time lapse of the PHM showing the anticipated recovery andresolution of the distortion of the PHM. In one scenario, a newdistortion (as for example induced by an adverse drug reaction) mayarise and the student will need to solve this distortion withoutallowing the original distortion from recurring.

In one embodiment the processor 200 may generate a dynamic two or threedimensional parallel construct from medical data, and to analyze theconstruct for dynamic distortions indicative of at least one of disease,drug reactions, age related declines in function, or clinical failures,the construct comprising a highly organized time matrix comprised ofgrouped, bonded, linked, related, encapsulated, or otherwise connected;perturbations, perturbation forces, recoveries, and recovery forces. Theprocessor 200 may generate a time-matrix construct of electronic medicaldata comprised of perturbation of particle densities linked to theforces which may have induced the perturbations.

In one embodiment a processor 200 may be programmed to generate oneprocessor 200 programmed to generate a time-matrix construct ofelectronic medical data comprised of perturbation of particle densitieslinked to the forces which may have induced the perturbations.Alternately or in combination a processor 200 may be programmed togenerate an image of electronic medical data comprised of dynamic colordisplays responsive to linked dynamic quaternaries comprised ofperturbations, perturbation forces, recoveries, and recovery forces.

A processor 200 may be programmed to generate a time matrix whichcomprises linked particle densities, exogenous forces, endogenousforces, perturbations, and recoveries and an analysis comprising;detection, identification, quantification, and tracking of cascadingperturbations, the forces inducing the cascading perturbations, as wellas triggering events (such as a surgical procedure) which may haveinduced the forces. Alternatively or in combination at least oneprocessor 200 may be programmed to process medical data, detect agrouping of linked perturbations and perturbation forces, detect acascade comprised of the grouping, search the medical data for at leastone apical force which induced the cascade, and output an indication ofthe apical force.

A processor 200 programmed to process medical data, generate a timematrix comprised of the medical data, detect a grouping of linkedperturbations and perturbation forces along the time matrix, detect acascade comprised of the grouping among the time matrix, detect agrouping of linked recoveries and recovery forces along the time matrix,and output a dynamic timed image responsive to the time matrix.Alternatively or in combination at least one processor 200 may beprogrammed to convert the medical data into a time series matrix ofobjects comprised of linked objects of binaries comprised ofperturbations and the perturbation forces which induced theperturbations, and recoveries, and the recovery forces, and recoveryforces which induced the recoveries, store the time series matrix in adata repository, and periodically adding new binaries onto the matrixover time.

A processor 200 may be programmed to process medical data, generate atime matrix comprised of the medical data, detect a grouping of linkedperturbations and perturbation forces along the time matrix, identifylinkages which comprise history primers and, upon the detection of oneor more primers generate one or more questions for the patient to focusthe history in response to the linkages. Alternatively or in combinationat least one processor 200 may be programmed to identify linkages whichcomprise image primers and, upon the detection of one or more imageprimers generate one or more tests to be performed on the patient tocomplete the image.

One processor 200 may be programmed to generate an image of a patient'smedical data comprised of at least one perturbations, perturbationcascade, force binary, force binary cascade, quaternary, orpolyquaternary. The processor 200 may generate a parallel construct suchas a time matrix of a patient's medical data comprised of a plurality oflinked binaries wherein each binary is comprised of a perturbation andthe force which induced the perturbation, or wherein each binary iscomprised of a perturbation and the force which induced theperturbation, or wherein each binary is comprised of a perturbation andthe force which induced the perturbation.

A processor 200 may be programmed to order tests based on detection ofat least one force binary, force binary cascade, quaternary, or polyquaternary. The processor 200 may generate an image of a patient'smedical data comprised of at least one perturbations, perturbationcascade, force binary, force binary cascade, quaternary, orpolyquaternary, and identify an image primer comprising a partial imageof a clinical condition, and order tests and/or treatment based ondetection of the image primer to a render sufficient portion of theimage to identify the image and/or to treat the likely conditioninducing the image. One embodiment comprises a processor 200 programmedto generate a time matrix comprised of force binaries, the processor 200further being programmed to provide a process for linking of lab valuesin the time matrix to build a distortion so that the student may learnto construct mental images of the dynamic building process of humanpathophysiologic distortions in response to disease or adverse drugreactions.

A processor 200 may be to identify a clinical condition or pattern,based on the clinical condition or pattern calculate a potential worstcase path or value of the lab value, identify the retesting time basedon the minimum change of the parameter which would have clinicalrelevance and which may include the expected delay in lab reporting inrelation to the ordered testing time, and order the lab test for afuture time, based on the calculated retesting time.

A processor 200 may be programmed to identify the clinical condition orpattern, and based on the clinical condition or pattern calculate orproject a potential path range over time of at least a first particledensity, and output the expected path range of the first particledensity on a display. The processor 200 may be further programmed to,based on the clinical condition or pattern, calculate or project apotential path range of the first particle density, calculate or projectat least one other path range of at least a second particle densitybased on the first particle path.

The processor 200 may be further programmed to, based on the clinicalcondition or pattern, calculate a potential path range of at least afirst particle density, and calculate a plurality of path ranges for aplurality of other particle densities based on the clinical conditionand the first particle pathway. The processor 200 may be furtherprogrammed to, based on the clinical condition or pattern, calculate apotential path range of at least a first particle density and calculatea path range for a cascade of particle densities based on the clinicalcondition or pattern and the calculated or projected path range of thefirst particle density.

One processor 200 may programmed to compose interconnected cascades ofphysiological occurrences by combining into a quaternary four elementsor objects comprising, a perturbation, at least one perturbation forcewhich is capable of inducing and may have induced the perturbation, arecovery, at least one recovery force which is capable of inducing andmay have induced the perturbation. The quaternary may be defined or itsconstruction triggered by the detection of at one of the elements. Thequaternary may be characterized as solved or unsolved. A quaternary maybe are considered solved when all four elements are included, thecollection of perturbation forces is determined to be compatible withthe perturbation, and the collection of recovery forces is determined tobe compatible with the recovery. A perturbation in one quaternary may bea perturbation force in another quaternary. A perturbation in onequaternary may be a recovery force in another quaternary. Any element ina quaternary may also be any element in a different quaternary.Interconnected cascades of quaternaries may be identified as candidatecausation models for a patient condition. At least one candidate apicalforce 700 may be determined as the first perturbation force within acascade. The identification of apical force may 700 be used by theprocessor 200 to identify or produce a diagnosis. At least one causationmodel may be displayed to a healthcare worker. At least two causationmodels may be compared. At least one preferred or “best fit” causationmodel may be determined. Unsolved quaternaries such as 702A and 702B ofFIG. 7 can be displayed and/or initiate testing or a change in frequencyof testing and/or be tracked as a time series and/or initiate an alarm.Solved and unsolved quaternaries 702A and 702B are identified on a colorweather map visualization. A healthcare worker may select and/or weightthe solution to a perturbation and/or recovery.

As discussed, in one embodiment perturbations, recoveries, binaries,quaternaries and polyquaternaries have seeking states and non-seekingstates. The “seeking gravity” of the state can depend on factors such asrisk, cost of finding solutions, and/or other factors. A high number ofunsolved perturbations or perturbations with a large “mass” (as defined,for example by a potentially high risk), generate an “unstable” imagewith high internal gravitations forces. The image is stabilized when theseeking state of the perturbations is mitigated or resolved by eitherfinding the matches or by being instructed (manually or automatically,as by internal “seeking buffers”) to stop seeking.

In one embodiment a game can be constructed to show how the programfunctions and to teach the pathophysiology of distortions. The programcan have a “game mode” allowing insertion of real or simulatedphysiologic data to generate a plurality of perturbations and forces. Atleast a portion of these will have no solutions so they will beginseeking. The presence of seeking perturbations can be designated bymoving or otherwise enhanced graphical avatars, geometric shapes, oricons. As a first perturbation finds its match(s) a resulting solvedbinary and/or quaternary (which may be seeking) is generated. A secondseeking perturbations may then find the solved binary and/or quaternaryas its solution. This may produce a automatically growing cascadecomprising a global solution and relieving the gravitationalinstability. All of this can occur on a graphical image building amoving image as the components seek each other and come together to fora solved game.

In one embodiment the seeking is bilateral and the gravitational pullbetween two mutual seekers is defined by a new and often much largerforce related to the risk associated with the combination of theseekers. In an example a perturbation comprising a fall in bicarbonateis seeking a plurality of perturbation forces, one of which is a rise inabsolute band count. A rise in absolute band count is also seeking aplurality of perturbation forces is a fall in bicarbonate. If a rise inabsolute band count finds a fall in bicarbonate they are attracted by avery high force because the combination suggests a time dependentdangerous condition which can evolve rapidly.

In one embodiment, vector analysis is performed to provide insight intodiagnostic paths for patient conditions, failure modes, and clinicalfailures. Patient conditions, failure modes, and clinical failures areassociated with one or more object types. Each object type has a set ofinstances (occurrences) per patient. Vector analysis reviews the pathsleading to the condition or failure in time to provide insight into theevolution of perturbation and/or recovery. The analysis also provides amethod for improving retrospective quality review. Further, vectoranalysis can be utilized to refine the definition of occurrences withinan image or cascade to improve sensitivity, specificity or othercorrelativity feature.

A complex object type represents a tree structure of other object typesof which it is composed. For example, if X is a binary of type A andtype B, then X has a tree structure in which X is a tree and A and B areleaves of the tree. In this simple case, if X was associated with acondition, failure mode or clinical failure then vector analysis wouldconsider X to have two diagnostic paths: A->X, B->X. In the domain (XAB)A and B are considered initial types and X is considered a diagnostictype. Were a single instance of X to be identified for a patient, thenthere would be two diagnostic path traversals (OA1->OX1) and (OB1->OX1)where OA1, OB1, and OX1 are Occurrences of types A, B and X respectivelyin which OA1, OB1 are components of the binary OX1.

In more complex scenarios, a diagnostic path traversal would have thestructure of I->L1->Ln->D where I is the initial occurrence, D is theoccurrence indicative of the condition and L1 through Ln are linkingoccurrences. For example, in FIG. 8 a single diagnostic path traversalis shown. The path with a solid line (as opposed to a dotted line)indicates the actual traversal of one or more occurrences. FIG. 8 showsa single traversal traveling from LacticAcidHigh 802 through Acidosis804 through Acidification 806 throughModerateInflammationAndAcidification 808 throughInflmmationAndAcidification 810 to Sepsis 812. As another example, inFIG. 9 we can identify three complete diagnostic path traversals. Thefirst diagnostic path traversal has an initial occurrence type ofBandsHighModerate 902 and then proceeds through ModInflammatoryIndicator904 then InflammationAndPlateletDeficit 906 and then to Sepsis 908. Thesecond diagnostic path traversal has an initial occurrence type ofBandsAbsRiseModerate 910 and then proceeds throughModInflammatoryIndicator 904 then InflammationAndPlateletDeficit 906 andthen to Sepsis 908. The third diagnostic path traversal has an initialoccurrence type of PlateletsLowMild 912 and then proceeds throughPlateletDeficit 914 then InflammationAndPlateletDeficit 906 and then toSepsis 908.

Given a patient matrix, vector analysis will derive 0 or more completediagnostic path traversals. For example, given the domain (XAB) usedabove, if a patient has two instances of the X object then (given thatboth components of a binary are required) there will be 4 completediagnostic path traversals.

Object types, such as classification which have optional or variantsources provide variability in paths. For example, if a classification Qis defined as R or S or T then in the domain (QRST) there are 3diagnostic paths: R->Q, S->Q and T->Q. If a patient has two instances ofQ then (given that a classification is created from any one of itssources alone) there will be two complete diagnostic path traversals.

Diagnostic path traversals provide the basic building block of vectoranalysis. In one embodiment, diagnostic path traversals are representedas records with the following fields: condition, patient id, diagnosticinstance id, diagnostic instance type, diagnostic instance earliestidentification time, initial instance id, initial instance type, initialinstance earliest identification time, diagnostic path traversalsignature, and primary sub-path.

In one embodiment, the diagnostic path signature is defined as a stringcontaining the path elements listed with a connector (e.g. “->”). Forexample a path signature from the complete traversal in FIG. 8 is thestring:“LacticAcidHigh->Acidosis->Acidification->ModerateInflammationAndAcidification->InflmmationAndAcidification->Sepsis”.

Since conditions are often defined in terms of a classification (i.e. astatement with a list of alternatives separated by an ‘or’ operator) itis useful to consider primary sub-paths into a condition. If, forexample, Sepsis is defined as “SIRSSevere orInflammatoryAugmentationProfound or SIRSandRespFailureMod” then thereare at least 3 primary sub-paths into Sepsis. If any of these threeelements specified are themselves simple classifications (e.g. a list ofalternatives separated by an ‘or’ operator) then the members theclassification will replace the original classification as primarysub-paths. This process is repeated until all primary sub-paths areidentified. Therefore, the primary sub-path is a direct unqualifiedgateway into the condition. More formally this is specified as a typefor which an occurrence will be guaranteed to become an instance whichindicates the condition but for which arriving occurrences to the typeare not.

Primary sub-paths provide a top-level differentiation of diagnosticpaths and are much more cognitively manageable than an entire diagnosticpath.

In one embodiment the diagnostic path traversal record contains anyreference information necessary to access the occurrence instancesrepresented in the path.

In one embodiment additional key characterizes (e.g. Severity Category)are included in the record and in the path signature to provideadditional specification.

In addition to instances of complete diagnostic path traversals, vectoranalysis identifies and maintains partial path traversals. Furtheranalysis can be done to identify the reasons that the path did notbecome a complete diagnostic path traversal. Failure reasons are derivedby determining all of the next steps that could have been taken. Foreach candidate next step a failure reason (e.g. no SevereInflammationfound within 1 day) is derived and stored.

In one embodiment, failure reasons are stored by the real-time engineduring execution. In one embodiment, a minimum distance is specifiedindicating the number of steps required from the end of the pathtraversal to the type indicating the condition. In one embodimentadditional information is provided to quantify the failure (e.g.indicating by “how much” a qualification was missed).

In one embodiment partial diagnostic path traversals are aggregatedalong with complete diagnostic path traversals. These records includefailure reasons, distance from diagnosis and potential primary-sub pathsto name a few.

Having a comprehensive set of partial and complete diagnostic pathtraversal records provides a powerful mechanism for analysis andderiving insight into patient condition, disease evolution and recovery.For example, in FIG. 10 the filtering of path traversals byModInflammatoryIndicator 1002 shows initial types, paths and primarysub-paths through which Sepsis identification was accomplished for agiven patient at a specific point in time. FIG. 10 shows, for example,that 3 primary sub-paths used for the traversals(SeqentialInflammationInjury 1004, InflammationAndPlateletDeficit 1006and InflammationAndAcidification 1008) are dependent on theidentification of ModInflammatoryIndicator 1002. Further, it is clearthat 5 different initial types (BandsHighModerate 1010,BandAbsHighModerate 1012, BandsAbsRiseModerate 1014,NeutrophilsAbsHighMild 1016 and WBCHighModerate 1018) are triggeringModInflammatoryIndicator 1002.

Alternatively occurrence definitions can be analyzed in the context ofsensitivity/specificity analysis or other statistical analysis to refinethe definitions either automatically or through the direction of amedical expert. In either case, metrics can be derived by sorting,filtering and aggregating this set. Analysis can be executed againstlarge patient populations, sub-groups or single patients to name a few.

For example, given a patient set, vector analysis can indicate what thetop 5 initial paths to Sepsis are for patients over 60 who contractedSepsis in-hospital.

Basic metrics can be derived around an occurrence within the traversal,a type within the traversal, an initial occurrence, an initialoccurrence type, a condition, a diagnostic path, a path signature, atraversal signature, a primary sub-path, a potential primary sub-path,or a failure reason to name a few. Metrics can be derived in counts andpercentages both of instances and/or patients.

In one embodiment, a time series of metrics is derived by performing orderiving vector analysis at multiple points in time over the patientstay. In one embodiment, metrics are derived continuously per pointreceived within the system. It is particularly useful for acomprehensive understanding of condition evolution that filters and atime-series approach be used in concert. In one embodiment a patientgroup is filtered down to limit the set to patients which acquired thecondition while being monitored (e.g. in which initial identification ofthe condition is >28 hours past admit time) and a time series of metricpoints is created using time in reference to the initial conditionidentification point. For example, starting with 18 hours before initialidentification of Sepsis the primary sub-path percentages are sampled in2 hour increments. In this way a set of metric time series is createdthat can be further analyzed. For example, it may be determined that aparticular primary sub-path is the ranked as the highest sub-path forthe first 12 hours of Sepsis within a specific patient group.

Within these time-series patterns of thresholds, trends, binaries,images and repeating occurrences to name a few can be derived, analyzedand displayed. For example it may be determined that a particularprimary sub-path tends to increase from 6 hours since identification to24 hours since identification and then fall off.

Metric analysis has a wide range of applicability. It can be used forreal-time analysis of patient state, analysis of overall disease andrecovery evolution in patient populations, and in support of conditionscript creation/refinement to name a few.

In terms of script refinement/creation vector analysis can provide bothfalse-positive and false-negative analysis.

In one embodiment, false-positive analysis is accomplished by limitingthe patient set to patients that have been identified to falsepositives. Further, within that group, sub-groups can be defined andfocused on. For example, a researcher could choose to work on asub-group of false positives that are identifying patients through aspecific primary sub-path (e.g. SIRSandRespFailureMod). Once a patientgroup has been defined (or a single patient selected) vector analysisprovides insight in to the initial occurrence (events that becamecomponents of the condition), paths, and primary sub-path.

Top Initial Occurrence Types can be identified and further analysis canbe done on them. For example, range analysis can show a distribution ofvalues that fell within the range required indicating whether a smalladjustment in the qualification range may eliminate a number of pathtraversals. In one embodiment, this analysis is automated to combinerange-analysis with “what if” scenarios to find range adjustments thateliminate false-positives without creating false negatives.

Top Primary Sub-Paths gives a high-level insight into howfalse-positives are reaching the condition providing direction into whatadjustments will be most effective.

Hot paths can give more detailed insight into how the approach vectorsare being reached. Traversals can further be analyzed to find hotlinks—specific relationships that may be defined to liberally in termsof time or qualification.

In one embodiment, false-negative analysis is accomplished by looking atpartial diagnostic path traversal within a condition and reviewingfailure reasons within a false-negative group of patients. Near pathscan be determined by finding failure paths with the minimum distancevalues. Ranking can be done by distance or quantification of failure toname a few.

In one embodiment partial and complete traversals are viewed, sorted,filtered, grouped and ranked at the same time. In this way truepositives and true negatives can also be engaged to strengthen thescript by increasing the mean distance from diagnosis in true negativesor increasing the mean number of identification paths in true positives.

Further, in one embodiment, ignore lists can be maintained to focuson/strengthen aspects of scripts. Ignore lists can be of occurrenceswithin the traversal, types within the traversal, initial occurrences,initial occurrence types, conditions, diagnostic paths, path signatures,traversal signatures, primary sub-paths, potential primary sub-paths andfailure reasons to name a few. Ignore lists can be added, updated,deleted and stored.

In one embodiment the brain is identified as a system in the matrix (anddistortions may be shown on a weather map or other visualization. Cellsmay be defined by EEG analysis, for example the detection of severeslowing (a perturbation) and then the cause (the perturbation force) ofthe severe slowing sought to solve the force binary. Other perturbationssuch as seizures, or frequent arousals. Outputs of cognitive testing maybe converted to R values and/or presented in cells and treated asperturbations in the matrix. In this way persistent perturbation ofbrain function, for example after sepsis, comprise distortions in thematrix which may be tracked using visualizations such as persistentstorm cells on a portion of the map relating to the brain.

As described earlier in one embodiment features of perturbations(slopes, magnitude, duration, and absolute values) are quantized inrelation to phenotypic or other reference range of the features. In asimilar way, features of relational perturbations (such aspathophysiologic divergence (decoherence) may be quantized in relationto phenotypic or other reference range of the features. The term“decoherence” may be used interchangeably with pathophysiologicdivergence and with refers to the pattern and/or dynamic behavior orrelational pattern and/or dynamic behavior of a density which is notexpected. For example, the pattern or dynamic behavior of a biologicparticle density may be described as decoherent or decoherent inrelation to the matrix, when the pattern or dynamic behavior isexhibiting pathologic behavior. The pattern or dynamic behavior of abiologic particle density may be described as decoherent in relation tothe phenotypic matrix, when the pattern or dynamic behavior isexhibiting pathologic behavior. The pattern or dynamic behavior of abiologic particle density may be described as decoherent or decoherentin relation to a distortion when the pattern or dynamic behavior isexhibiting behavior which is not the expected pattern or behavior giventhe pattern or behavior of the distortion.

The quanta of the features of perturbations or recoveries may be mappedon fixed or movable organelles each of which is responsive to changes inthe feature which is mapped on the organelle. Organelles may bepositioned in a predefined format (such as, in aggregate, defining ahexagon or another shape) within fixed or movable “perturbation cells”or “recovery cells” respectively. “Perturbation force cells” and“recovery force cells” with corresponding organelles responsive to thesecells may be on a mapped on the system and/or organ region to which theperturbation corresponds. Regions which comprise relational regions (forexample a combined inflammatory-hemostatic region) may be provided,which are comprised of cells which are “relational perturbation cells”,the organelles of relational perturbation cells being responsive torelational features of the perturbations. Each organelle may change (achange may comprise for example, a change in color, density, texture,shape, blinking frequency, or another change) in response to changes inthe feature which is mapped to that organelle.

This generates a quantized motion image of a distortion and recoveryfrom the distortion and of the forces inducing the distortion and therecovery. By placing all of the cells and organelles in fixedrelationships on a preformatted map with a known format, a large mass ofcomplex relational quantized data is presented in relation to aphenotypic, normal, or baseline state so that distortions due to a onetype of pathology exhibit predictable ranges of images on thepreformatted map which are useful for facilitating the detection,identification, quantification, characterization, and tracking of thatpathology type.

In addition the quantized motion image or fixed snapshots or shortsegments can be imaged and are analyzable by image based pattern and/orpixel recognition systems or other analysis systems.

As discussed, in one embodiment, perturbations, features or quantaderived from the perturbations and/or features may be converted intoimage components which may comprise; cells, organelles, shapes, barcodes, shape codes, shades, colors, shapes, numbers, and/or pixels, orother image component renderings derived from the perturbations,features, or quanta.

The image components may be aggregated in relation to the perturbationsfrom which the features are derived and/or in relation to thephysiologic system to which the perturbation or features relate and/orin relation their relation to treatment, to which the perturbation orfeatures relate.

Image components may be aggregated in relation to whether they areperturbations, perturbation forces, recoveries, or recovery forces. Theymay also be derived as relational image components and/or aggregated asrelational image components. They may be mapped onto relational systems,or maps for relational perturbations, perturbation forces, recoveries,or recovery forces, binaries quaternaries or other relational patterns.

Any of these image components may be placed into fixed and predeterminedpositions on the display to render images which would be substantiallyidentical same if the perturbations and features are substantiallyidentical thereby producing reliable image changes. These can then besequenced over time segments and displayed as fixed or changing imagesor the predetermined format. Training sets of images can then bedisplayed to one or more image recognition system, as are known in theart, to train the image recognition system to recognize the clinicalcondition by imaging the displays.

Large archives of displays can be derived using reliable, definitive,gold standards to train the image recognition systems.

The converting the biologic particle densities and other physiologicdata into fundamental features, generating image components responsiveto the fundamental features and then generating predefined imagesmapping provides a data processing and mapping and displaying systemwhich takes advantage of advances made in the field of image recognitionby the conversion of these complex data sets into images of sufficientgranularity and dynamic relational granularity to allow subtle imagedifferences to be recognized in the training set and then applied in therecognition of the image under test.

The maps which display the image components derived from theperturbations, forces, perturbation features, and/or force features canbe standardized, as with the development of an ASTM standard or ISOstandard for use of the human or animal biologic particle mapsworldwide.

A field of image recognition professionals, similar to the field ofradiology may be developed, wherein the professionals are trained in theimages and the pathophysiology of the diseases under test and areprovided other images, such as the time series matrices of the data toover read the diagnostic output of the image recognition software andthereby protect outlier patients.

In one embodiment the image is divided into components or sections andeach section, grouping of sections, and/or the entire image may be usedto train an image recognition system. The sections section, grouping ofsections, and the entire image may be presented to the recognitionsystem in sequence or otherwise marked for their timing relationships.

The image recognition system can then generated probabilities for thediagnoses which at least partially matched by the image or imagesegment. The image recognition system or processor 200 may also generatea probability matrix or other probability construct and/or a group oftime series or a matrix of time series of the probabilities generated.

In one embodiment the time series matrix of probabilities is objectifiedand processed in the same way as the time series matrix of biologicparticle densities to generate perturbations of probabilities, featuresof perturbations, and image components of the probabilities, which canthemselves be mapped to generate an training archive of probabilityimages which are used to train an image recognition systems. Thisprocess may be recursive.

One embodiment comprises a medical device for monitoring dynamicpatterns of biologic particle densities comprising a processor 200programmed to detect and analyze perturbations of biologic particledensities, detect and analyze features of biologic particle densitiesperturbations and to convert the perturbation features into discreetperturbation feature quanta in relation to a phenotypic, baseline orexpected range of the perturbation features.

One embodiment is programmed to generate a first set of imagesresponsive to the perturbations, generate second set of imagesresponsive to the perturbation feature quanta, aggregate the first setand the second set into a time-lapsable motion image to generate amotion image of visualization of combined of perturbations andperturbation feature quanta.

The device may be further programmed to detect and analyze forces whichinduced or caused said perturbations of biologic particle densities,detect and analyze features of biologic particle densities forces,convert the force features into discreet quanta in relation to aphenotypic, baseline or expected range of the force features and togenerate a third set of images responsive to the forces and generatefourth set of images responsive to the force feature quanta.

In one embodiment the processor 200 is programmed to aggregate the thirdset and the fourth set into a time-lapsable motion image to generate amotion image of visualization of combined of the forces and the forcefeature quanta. The processor 200 may be future programmed to aggregatethe first set and the second set with the third set and the fourth setinto a time-lapsable motion image to generate a motion image ofvisualization of combined perturbations and perturbation feature quantaand forces and the force feature quanta. Quanta may be defined bycolors, gradation of colors, integers and ascending and descendingsequences of integers or other discrete gradation methods.

In one embodiment perturbation, perturbation forces, recovery andrecovery forces and/or their features are rendered as hexagons 1102placed within related clinical space systems as shown in FIG. 11. In oneembodiment, the hexagons have a fixed location. In one embodiment, thelocation is based on the severity of the quanta to which the hexagonsare responsive. In one embodiment, the relative locations are responsiveto severity and/or relationships within and among the associatedperturbations and associated features. Alternatively other visualaspects of the hexagons are responsive to the related quanta such as thesize, orientation, fill color or texture, border color or texture,transparency to name a few.

In one embodiment, as shown in FIGS. 12 through 14, perturbations,perturbation forces, recoveries and recovery forces and/or theirfeatures are rendered as bars 1202 across a two dimensional area inwhich the location and length of the bar is based on the start and endtime of the associated perturbation or recovery. The vertical locationis set by the type of the perturbation or recovery and may be furthergrouped by clinical space as shown in FIGS. 12 through 14. Other visualaspects of the bars are responsive to the related quanta such as thesize, fill color or texture, border color or texture, transparency toname a few.

FIG. 13 depicts an image of a sepsis patient which recovered from sepsisin which perturbations, perturbation forces, recoveries and recoveryforces and/or their features rendered as bars 1302 across a twodimensional area in which the location and length of the bar are basedon the start and end time of the associated perturbation or recovery andthe vertical location is set by the type of the perturbation or recoverygrouped by clinical space.

FIG. 14 depicts an image of a long-term severe sepsis patient in whichperturbations, perturbation forces, recoveries and recovery forcesand/or their features rendered as bars 1402 across a two dimensionalarea in which the location and length of the bar are based on the startand end time of the associated perturbation or recovery and the verticallocation is set by the type of the perturbation or recovery grouped byclinical space.

The bars 1202, 1302, 1402 may be provided in a fixed location and befilled in or otherwise enhanced, modified or visible, only if the dataneeded to generate the bar was available to the processor 200. Although,predominately perturbations are displayed in the exemplary maps of FIGS.12 through 14. Each feature or a wide range of relevant features may bemapped onto the map. In this example, a map may contain hundreds orthousands of potential bars 1202, 1302, 1402 which can be very thinlines and/or very thin linear patterns for the purpose of providing themon a single view.

In one embodiment, as shown in FIG. 15, hexagons 1502A, 1502B aregrouped such that the perturbation or recovery are placed in the center1504A, 1504B of additional hexagons responsive to the features andrelated quanta of the perturbation or recovery at the center of thegroup. Any number of features can be visually aggregated in this way. Inone embodiment, hexagons for the features are arranged spatially withinthe hexagon associated with the perturbation or recovery to which theyare associated. Once hexagons are visually aggregated in this way, asshown in FIG. 15, these clusters of hexagons can be themselvesaggregated according to relationships between perturbations,perturbation features, recoveries and/or recovery features. For example,as shown in FIG. 16, a pair of quaternaries (originally depicted in FIG.6) can be displayed as an image of perturbations 1602A, 1602B,recoveries 1606A, 1606B, perturbation forces 1604A, 1604B, and recoveryforces 1608A, 1608B using clustered hexagons as depicted in FIG. 15.FIG. 16 depicts a pair of related quaternaries showing that, in oneembodiment, quaternaries provide a spatial link which can beextrapolated to a greater number of quaternaries including allidentified.

In one embodiment, as shown in FIG. 17, perturbation 1702/recovery 1704pairs are visually decorated with the associated forces 1706 and 1708identified. Hexagon clusters for each perturbation, recovery and forceare fully expanded in the method depicted in and described by FIG. 15.In one embodiment these clusters are arranged spatially to display thedirection of the forces identified.

In one embodiment, a schematic of a complex time dimensionedpathophysiologic cascade with relationally enabled links is displayed asshown in FIG. 18. Using a combination of an alpha 1802 and beta 1804 theprocessor 200 may generate a unique binary object 1806, which enablesrelationally enabled connection to an otherwise non-connectable beta(which can also be another binary). Such combinations may also bedefined to classify a rise or a fall to whether it represents aperturbation or recovery from a prior perturbation (which may haveoccurred before the data collection. For example, a fall in absoluteneutrophils may be a perturbation (for example, when the neutrophilshave been destroyed or sequestered in the battle against themicroorganism) or a recovery (as an indication of a return of theabsolute neutrophil density toward the normal range as the infectionabates). If the processor 200 detects a rise in bands concomitant withthe fall in absolute neutrophils it may generate a unique “decoherencebinary” comprised of the rise in bands with the fall in absoluteneutrophils. Upon the identification of this decoherence binary, theprocessor 200 classifies the fall in absolute neutrophils as aperturbation and not a recovery.

FIG. 19 is a block diagram of an example of a computing device that canproject a path of at least one biologic particle density and a retestingtime for said biologic particle density of a patient. The computingdevice 1900 may be, for example, a hospital monitor, mobile phone,laptop computer, desktop computer, or tablet computer, among others. Thecomputing device 1900 may include a processor 1902 that is adapted toexecute stored instructions, as well as a memory device 1904 that storesinstructions that are executable by the processor 1902. The processor1902 can be a single core processor, a multi-core processor, a computingcluster, or any number of other configurations. The memory device 1904can include random access memory, read only memory, flash memory, or anyother suitable memory systems. The instructions that are executed by theprocessor 1902 may be used to implement a method that can project a pathof at least one biologic particle density and a retesting time for saidbiologic particle density of a patient.

The processor 1902 may also be linked through the system interconnect1906 (e.g., PCI®, PCI-Express®, HyperTransport®, NuBus, etc.) to adisplay interface 1908 adapted to connect the computing device 1900 to adisplay device 1910. The display device 1910 may include a displayscreen that is a built-in component of the computing device 1900. Thedisplay device 1910 may also include a computer monitor, television, orprojector, among others, that is externally connected to the computingdevice 1900. In addition, a network interface controller (also referredto herein as a NIC) 1912 may be adapted to connect the computing device1900 through the system interconnect 1906 to a network (not depicted).The network (not depicted) may be a cellular network, a radio network, awide area network (WAN), a local area network (LAN), or the Internet,among others.

The processor 1902 may be connected through a system interconnect 1906to an input/output (I/O) device interface 1914 adapted to connect thecomputing device 1900 to one or more I/O devices 1916. The I/O devices1916 may include, for example, a keyboard and a pointing device, whereinthe pointing device may include a touchpad or a touchscreen, amongothers. The I/O devices 1916 may be built-in components of the computingdevice 1900, or may be devices that are externally connected to thecomputing device 1900.

In some embodiments, the processor 1902 may also be linked through thesystem interconnect 1906 to a storage device 1918 that can include ahard drive, an optical drive, a USB flash drive, an array of drives, orany combinations thereof. In some embodiments, the storage device 1918can include a path projector module 1920. The path projector module 1920can process laboratory data from a patient or from a data repository;identify an evolving pattern of a plurality of biologic particledensities, and identify a medical condition which induced the evolvingpattern. In some embodiments, the path projector module 1920 can alsocalculate a potential future adverse pattern or trajectory of thebiologic particle density over time, wherein the calculation isresponsive to said evolving pattern and the medical condition.

It is to be understood that the block diagram of FIG. 19 is not intendedto indicate that the computing device 1900 is to include all of thecomponents shown in FIG. 19. Rather, the computing device 1900 caninclude fewer or additional components not illustrated in FIG. 19 (e.g.,additional memory components, embedded controllers, additional modules,additional network interfaces, etc.). Furthermore, any of thefunctionalities of the path projector module 1920 may be partially, orentirely, implemented in hardware and/or in the processor 1902. Forexample, the functionality may be implemented with an applicationspecific integrated circuit, logic implemented in an embeddedcontroller, or in logic implemented in the processor 1902, among others.

FIG. 20 is a process flow diagram of an example method for projecting apath of at least one biologic particle density and a retesting time forsaid biologic particle density of a patient. The method 2000 can beimplemented with a computing device, such as the computing device 1900of FIG. 19.

At block 2002, the path projector module 1920 can process laboratorydata from a patient or from a data repository. At block 2004, the pathprojector module 1920 can identify an evolving pattern of a plurality ofbiologic particle densities. At block 2006, the path projector module1920 can identify a medical condition which induced the evolvingpattern. At block 2008, the path projector module 1920 can calculate apotential future adverse pattern or trajectory of the biologic particledensity over time, said calculation being responsive to said evolvingpattern and the medical condition

The process flow diagram of FIG. 20 is not intended to indicate that theoperations of the method 2000 are to be executed in any particularorder, or that all of the operations of the method 2000 are to beincluded in every case. Additionally, the method 2000 can include anysuitable number of additional operations.

One of ordinary skill in the art will appreciate the technical effectdescribed herein which enables projecting a path of at least onebiologic particle density and a retesting time for said biologicparticle density of a patient. Some embodiments described herein havethe effect of identifying a medical condition that induced an evolvingpattern and calculating a potential future adverse pattern of abiological particle density based on the evolving pattern.

Conditional language used herein, such as, among others, “can,” “may,”“might,” “could,” “e.g.,” and the like, unless specifically statedotherwise, or otherwise understood within the context as used, isgenerally intended to convey that certain embodiments include, whileother embodiments do not include, certain features, elements and/orsteps. Thus, such conditional language is not generally intended toimply that features, elements and/or steps are in any way required forone or more embodiments or that one or more embodiments necessarilyinclude logic for deciding, with or without author input or prompting,whether these features, elements and/or steps are included or are to beperformed in any particular embodiment.

While the above detailed description has shown, described, and pointedout novel features as applied to various embodiments, it will beunderstood that various omissions, substitutions, and changes in theform and details of the device or process illustrated may be madewithout departing from the spirit of the disclosure. As will berecognized, certain embodiments described herein may be embodied withina form that does not provide all of the features and benefits set forthherein, as some features may be used or practiced separately fromothers. The scope of some embodiments is indicated by the appendedclaims rather than by the foregoing description. All changes which comewithin the meaning and range of equivalency of the claims are to beembraced within their scope.

The term laboratory measurements, values, and densities may comprisecalculated values or may comprise the actual measurements and valuesindicative of particle densities, particle characteristics, or otherphysical components or characteristics in, or of, the sample under testsuch as the blood. The analog or digital outputs of automatedmeasurements derived from automated systems (such as automatedhematology or chemistry instrumentation) may be received and convertedto time series when multiple sequential samples are available. Suchmeasurements may be derived from florescence, impedance volume, forexample with direct current, radiofrequency conductivity with impedanceaperture, laser light scattering, photon spectral absorption, antibodyprobes, PCR amplification, chemical reactions, or many other methods asare well known in the art. In many situations such measurements actuallycomprise the densities or characteristics of the biologic particles buthave not yet been formally converted into the formal density orcharacteristic values which healthcare workers are accustomed to seeing,for example in an automated complete blood count. In one embodimentthese signal may be used directly by the processor 200 to generate,perturbations, forces, and recoveries and features of perturbations,forces, and recoveries before converting them into the formal density orcharacteristic values which healthcare workers are accustomed to seeing

With this approach, time series or timed groupings of these measurementsor values may be generated. Perturbations, features of perturbations,forces, features of forces, and recoveries and features of recoveriesmay be identified in these signals and/or converted into objects. Thesemay be used to derive image components, images, sequenced of imagesand/or mapped and presented to an image recognition system. These may becombined with the calculated or estimated density values to create amore comprehensive map. Such measurements render rawer outputs which maybe plotted directly and although some represent density equivalentsothers contain features or relational patterns over time which may havebeen lost in the quantification processes associated with conversion ofthese analog or digital signals into to the formal density orcharacteristic values which healthcare workers are accustomed to seeing.

Example Embodiments

In some embodiments, a method for projecting a path of at least onebiologic particle density and a retesting time for said biologicparticle density of a patient comprises processing, via a processor,laboratory data from the patient or from a data repository. The methodcan also include identifying, via the processor, an evolving pattern ofa plurality of biologic particle densities and identifying, via theprocessor, a medical condition which induced the evolving pattern.Furthermore, the method can include calculating, via the processor, apotential future adverse pattern or trajectory of the biologic particledensity over time, said calculation being responsive to said evolvingpattern and the medical condition. In some examples, the method alsoincludes determining, via the processor, the retesting time based on atleast a minimum change of the biologic particle density which hasactionable clinical relevance and ordering a lab test for a future timeresponsive to said retesting time. In addition, the method can alsoinclude calculating or receiving and inputting, via the processor, anexpected delay in lab reporting in relation to the ordered testing timeand identifying the retesting time responsive to said expected delay.

In some embodiments, the method also includes constructing, via theprocessor, a time matrix of a plurality of perturbations of biologicparticle densities and projecting the future pattern or trajectory inrelation to the time matrix. Furthermore, the method can includegenerating, via the processor, a time lapsable motion image responsiveto said pattern or trajectory. In addition, the method can includegenerating, via the processor, a color rendering of an image responsiveto said matrix and projecting the pattern or trajectory as a colorrendering. In some examples, the method includes generating, via theprocessor, a color rendering of an image responsive to said matrixhaving an appearance of weather and projecting the path as a timelapsable color rendering having an appearance of a path of weatherprogression over time.

In some embodiments, a method for processing biologic particle densitydata and for projecting a path of biologic particle densities of apatient with an adverse clinical condition comprises receiving, via aprocessor, biologic particle density data. The method can also includecalculating, via the processor, based on at least one biologic particledensity and said adverse clinical condition, at least a first potentialfuture path range of at least one biologic particle density.Furthermore, the method can include outputting, via the processor, atleast one potential future path range on a display. In some examples,the method includes projecting, via the processor, at least a potentialpath range of a plurality of biologic particle densities which are eachresponsive the said clinical condition. Furthermore, the method caninclude generating, via the processor, a time lapsable motion image of,or responsive to, the path range.

In some examples, the method includes generating, via the processor, acolor rendering of, or responsive to, the path range and to project thepath range as a color rendering. In addition, the method can alsoinclude generating, via the processor, a color rendering of, orresponsive to, the path range having an appearance of weather and toproject the path range as a color rendering having an appearance of apath range of weather progression over time. Furthermore, the method caninclude constructing, via the processor, a time matrix of a plurality ofperturbations of the biologic particle densities and generating a colorrendering of an image of the time matrix having an appearance of weatherand to project the path range as a time lapsable color rendering havingan appearance of a path range of weather progression over time.Additionally, the method can include outputting at least a worst, nearworst, or severe potential future path range on a display. In addition,the method can include generating a graphical rendering of the pathrange and to project the path range as a graphical rendering.

In some embodiments, a method for projecting a path of biologic particledensities of a patient with an adverse clinical condition comprisesprocessing, via a processor, biologic particle density data from thepatient or from a data repository. The method can also includeanalyzing, via the processor, the dynamic relational pattern of theplurality of biologic particle densities and projecting or calculating,via the processor, based on the clinical condition and the pattern, apotential path range of at least a one biologic particle density. Inaddition, the method can include outputting, via the processor, the pathrange on a display. In some examples, the method also includesprojecting or calculating, via the processor, a potential second pathrange of at least a second particle density; and outputting the secondpath range on a display.

In some embodiments, a method for projecting a path of particledensities of a patient with an adverse pattern of biologic particledensities comprises processing, via a processor, biologic particledensity data from the patient or from a data repository. The method canalso include detecting, via the processor, a plurality of perturbationsof a plurality of biologic particle densities and detecting, via theprocessor, at least one pattern of biologic particle densityperturbations. Additionally, the method can include analyzing, via theprocessor, said pattern of biologic particle density perturbations andprojecting or calculating, via the processor, based on the pattern, aplurality of potential path ranges for a plurality of particledensities. In addition, the method can include outputting, via theprocessor, the plurality of potential path ranges on a display.

In some embodiments, a method for projecting a path of biologic particledensities of a patient with an adverse clinical condition comprisesprocessing, via a processor, biologic particle density data from thepatient or from a data repository. In addition, the method can includedetecting, via the processor, a plurality of perturbations of aplurality of biologic particle densities and detecting, via theprocessor, at least one pattern of at least one biologic particledensity perturbation. Furthermore, the method can include calculating,via the processor, based on said clinical condition and said at leastone pattern, a potential path range of the at least one biologicparticle density and outputting, via the processor, the expected pathrange on a display.

In some examples, the method can also include constructing, via theprocessor, a time matrix of a plurality of biologic particleperturbations. Furthermore, the method can also include generating, viathe processor, a time lapsable motion image of the path range. In someembodiments, the method includes generating, via the processor, a colorrendering of an image of, or responsive to, the matrix and to projectthe path range as a color rendering. The method can also includegenerating, via the processor, a color rendering of an image of, orresponsive to, the matrix, the image having an appearance of radarweather display and to project the path range as a color renderinghaving an appearance of a path range of weather progression over time.Additionally, in some examples, the method includes generating, via theprocessor, a motion image of, or responsive to, the matrix and the pathrange. The method can also include generating, via the processor, amotion image of, or responsive to, the matrix and the path range, theimage having the appearance of a radar weather display with the pathrange of being time lapsable and projectable over a future time period.

What is claimed is:
 1. A method for projecting a path of at least onebiologic particle density and a retesting time for said biologicparticle density of a patient, comprising: processing, via a processor,laboratory data from the patient or from a data repository; identifying,via the processor, an evolving pattern of a plurality of biologicparticle densities; identifying, via the processor, a medical conditionwhich induced the evolving pattern; and calculating, via the processor,a potential future adverse pattern or trajectory of the biologicparticle density over time, said calculation being responsive to saidevolving pattern and the medical condition.
 2. The method of claim 1,further comprising determining, via the processor, the retesting timebased on at least a minimum change of the biologic particle densitywhich has actionable clinical relevance and ordering a lab test for afuture time responsive to said retesting time.
 3. The method of claim 2,further comprising calculating or receiving and inputting, via theprocessor, an expected delay in lab reporting in relation to the orderedtesting time and identifying the retesting time responsive to saidexpected delay.
 4. The method of claim 1, comprising constructing, viathe processor, a time matrix of a plurality of perturbations of biologicparticle densities and projecting the future pattern or trajectory inrelation to the time matrix.
 5. The method of claim 1, comprisinggenerating, via the processor, a time lapsable motion image responsiveto said pattern or trajectory.
 6. The method of claim 4, comprisinggenerating, via the processor, a color rendering of an image responsiveto said matrix and projecting the pattern or trajectory as a colorrendering.
 7. The method of claim 4, comprising generating, via theprocessor, a color rendering of an image responsive to said matrixhaving an appearance of weather and projecting the path as a timelapsable color rendering having an appearance of a path of weatherprogression over time.
 8. A method for processing biologic particledensity data and for projecting a path of biologic particle densities ofa patient with an adverse clinical condition comprising: receiving, viaa processor, biologic particle density data; calculating, via theprocessor, based on at least one biologic particle density and saidadverse clinical condition, at least a first potential future path rangeof at least one biologic particle density; and outputting, via theprocessor, at least one potential future path range on a display.
 9. Themethod of claim 8, further comprising projecting, via the processor, atleast a potential path range of a plurality of biologic particledensities which are each responsive to said clinical condition.
 10. Themethod of claim 8, comprising generating, via the processor, a timelapsable motion image of, or responsive to, the path range.
 11. Themethod of claim 8, comprising generating, via the processor, a colorrendering of, or responsive to, the path range and to project the pathrange as a color rendering.
 12. The method of claim 8, comprisinggenerating, via the processor, a color rendering of, or responsive to,the path range having an appearance of weather and projecting the pathrange as a color rendering having an appearance of a path range ofweather progression over time.
 13. The method of claim 8, comprisingconstructing, via the processor, a time matrix of a plurality ofperturbations of the biologic particle densities and generating a colorrendering of an image of the time matrix having an appearance of weatherand to project the path range as a time lapsable color rendering havingan appearance of a path range of weather progression over time.
 14. Themethod of claim 8, comprising outputting at least a worst, near worst,or severe potential future path range on a display.
 15. The method ofclaim 8, comprising generating a graphical rendering of the path rangeand to project the path range as a graphical rendering.
 16. A method forprojecting a path of biologic particle densities of a patient with anadverse clinical condition comprising: processing, via a processor,biologic particle density data from the patient or from a datarepository, analyzing, via the processor, the dynamic relational patternof the plurality of biologic particle densities, projecting orcalculating, via the processor, based on the clinical condition and thepattern, a potential path range of at least a one biologic particledensity, and outputting, via the processor, the path range on a display.17. The method of claim 16, comprising projecting or calculating, viathe processor, a potential second path range of at least a secondparticle density; and outputting the second path range on a display. 18.A method for projecting a path of particle densities of a patient withan adverse pattern of biologic particle densities comprising:processing, via a processor, biologic particle density data from thepatient or from a data repository; detecting, via the processor, aplurality of perturbations of a plurality of biologic particledensities; detecting, via the processor, at least one pattern ofbiologic particle density perturbations; analyzing, via the processor,said pattern of biologic particle density perturbations; projecting orcalculating, via the processor, based on the pattern, a plurality ofpotential path ranges for a plurality of particle densities; andoutputting, via the processor, the plurality of potential path ranges ona display.
 19. A method for projecting a path of biologic particledensities of a patient with an adverse clinical condition comprising:processing, via a processor, biologic particle density data from thepatient or from a data repository, detecting, via the processor, aplurality of perturbations of a plurality of biologic particledensities, detecting, via the processor, at least one pattern of atleast one biologic particle density perturbation, calculating, via theprocessor, based on said clinical condition and said at least onepattern, a potential path range of the at least one biologic particledensity; and outputting, via the processor, the expected path range on adisplay.
 20. The method of claim 19, comprising constructing, via theprocessor, a time matrix of a plurality of biologic particleperturbations.
 21. The method of claim 19, comprising generating, viathe processor, a time lapsable motion image of the path range.
 22. Themethod of claim 20, comprising generating, via the processor, a colorrendering of an image of, or responsive to, the time matrix and toproject the path range as a color rendering.
 23. The method of claim 20,comprising generating, via the processor, a color rendering of an imageof, or responsive to, the time matrix, the image having an appearance ofradar weather display and to project the path range as a color renderinghaving an appearance of a path range of weather progression over time.24. The method of claim 20, comprising generating, via the processor, amotion image of, or responsive to, the matrix and the path range. 25.The method of claim 23, comprising generating, via the processor, amotion image of, or responsive to, the matrix and the path range, theimage having the appearance of a radar weather display with the pathrange of being time lapsable and projectable over a future time period.